SECURITY AGREEMENT CALLIOPE CAPITAL CORPORATION. PROLINK HOLDINGS CORP. and EACH ELIGIBLE SUBSIDIARY NAMED HEREIN Dated: August 17, 2007
CALLIOPE
CAPITAL CORPORATION.
and
EACH
ELIGIBLE SUBSIDIARY NAMED HEREIN
Dated:
August 17, 2007
TABLE
OF CONTENTS
|
Page
|
||
1.
|
General
Definitions and Terms; Rules of Construction
|
1
|
|
2.
|
Loan
Facility
|
2
|
|
3.
|
Repayment
of the Loans
|
5
|
|
4.
|
Procedure
for Revolving Loans
|
5
|
|
5.
|
Interest
and Payments
|
5
|
|
6.
|
Security
Interest
|
7
|
|
7.
|
Representations,
Warranties and Covenants Concerning the Collateral
|
8
|
|
8.
|
Payment
of Accounts
|
10
|
|
9.
|
Collection
and Maintenance of Xxxxxxxxxx
|
00
|
|
00.
|
Inspections
and Appraisals
|
11
|
|
11.
|
Financial
Reporting
|
11
|
|
12.
|
Additional
Representations and Warranties
|
13
|
|
13.
|
Covenants
|
24
|
|
14.
|
Further
Assurances
|
32
|
|
15.
|
Representations,
Warranties and Covenants of Calliope
|
32
|
|
16.
|
Power
of Attorney
|
34
|
|
17.
|
Term
of Agreement
|
34
|
|
18.
|
Xxxxxxxxxxx
xx Xxxx
|
00
|
|
00.
|
Events
of Xxxxxxx
|
00
|
|
00.
|
Xxxxxxxx
|
00
|
|
00.
|
Waivers
|
38
|
|
22.
|
Expenses
|
39
|
|
23.
|
Assignment
By Calliope
|
39
|
|
24.
|
No
Waiver; Cumulative Remedies
|
40
|
i
TABLE
OF CONTENTS
|
Page
|
||
25.
|
Application
of Payments
|
40
|
|
26.
|
Indemnity
|
40
|
|
27.
|
Xxxxxxx
|
00
|
|
00.
|
Borrowing
Agency Provisions
|
41
|
|
29.
|
Notices
|
42
|
|
30.
|
Governing
Law, Jurisdiction and Waiver of Jury Trial
|
43
|
|
31.
|
Limitation
of Liability
|
44
|
|
32.
|
Entire
Understanding; Maximum Interest
|
44
|
|
33.
|
Severability
|
44
|
|
34.
|
Survival
|
45
|
|
35.
|
Captions
|
45
|
|
36.
|
Counterparts;
Facsimile Signatures
|
45
|
|
37.
|
Construction
|
45
|
|
38.
|
Publicity
|
45
|
|
39.
|
Joinder
|
45
|
|
40.
|
Legends
|
45
|
ii
This
Security Agreement is made as of August 17, 2007 by and among CALLIOPE CAPITAL
CORPORATION, a Delaware corporation (“Calliope”),
PROLINK HOLDINGS CORP., a Delaware corporation (the “Parent”),
and
each party listed on Exhibit
A
attached
hereto (each an “Eligible
Subsidiary”
and
collectively, the “Eligible
Subsidiaries”)
(the
Parent and each Eligible Subsidiary, each a “Company”
and
collectively, the “Companies”).
BACKGROUND
The
Companies have requested that Calliope make advances available to the Companies;
and
Calliope
has agreed to make such advances on the terms and conditions set forth in this
Agreement.
AGREEMENT
NOW,
THEREFORE, in consideration of the mutual covenants and undertakings and the
terms and conditions contained herein, the parties hereto agree as
follows:
1. General
Definitions and Terms; Rules of Construction.
(a) General
Definitions.
Capitalized terms used in this Agreement shall have the meanings assigned to
them in Annex
A.
(b) Accounting
Terms.
Any
accounting terms used in this Agreement that are not specifically defined shall
have the meanings customarily given them in accordance with GAAP and all
financial computations shall be computed, unless specifically provided herein,
in accordance with GAAP consistently applied.
(c) Other
Terms.
All
other terms used in this Agreement and defined in the UCC, shall have the
meaning given therein unless otherwise defined herein.
(d) Rules
of Construction.
All
Schedules, Addenda, Annexes and Exhibits hereto or expressly identified to
this
Agreement are incorporated herein by reference and taken together with this
Agreement constitute but a single agreement. The words “herein”, “hereof” and
“hereunder” or other words of similar import refer to this Agreement as a whole,
including the Exhibits, Addenda, Annexes and Schedules thereto, as the same
may
be from time to time amended, modified, restated or supplemented, and not to
any
particular section, subsection or clause contained in this Agreement. Wherever
from the context it appears appropriate, each term stated in either the singular
or plural shall include the singular and the plural, and pronouns stated in
the
masculine, feminine or neuter gender shall include the masculine, the feminine
and the neuter. The term “or” is not exclusive. The term “including” (or any
form thereof) shall not be limiting or exclusive. All references to statutes
and
related regulations shall include any amendments of same and any successor
statutes and regulations. All references in this Agreement or in the Schedules,
Addenda, Annexes and Exhibits to this Agreement to sections, schedules,
disclosure schedules, exhibits, and attachments shall refer to the corresponding
sections, schedules, disclosure schedules, exhibits, and attachments of or
to
this Agreement. All references to any instruments or agreements, including
references to any of this Agreement or the Ancillary Agreements shall include
any and all modifications or amendments thereto and any and all extensions
or
renewals thereof.
2. Loan
Facility.
(a) Revolving
Loans.
(i) (A) Subject
to the terms and conditions set forth herein and in the Ancillary Agreements,
Calliope may make revolving loans (the “Receivable
Revolving Loans”)
to the
Companies from time to time during the Revolver Term which, in the aggregate
at
any time outstanding, will not exceed the lesser of (x) (I) the Capital
Availability Amount minus (II) such reserves as Calliope may reasonably in
its
good faith judgment deem proper and necessary from time to time (the
“Reserves”)
minus
(III) the aggregate outstanding principal balance of the Purchase Order
Revolving Loans and (y) an amount equal to (I) the Accounts Availability minus
(II) the Reserves. The amount derived at any time from
Section 2(a)(i)(A)(y)(I) minus 2(a)(i)(A)(y)(II) shall be referred to as
the “Receivable
Formula Amount.”
(B) Subject
to the terms and conditions set forth herein and in the Ancillary Agreements,
Calliope may make additional revolving loans (the “Purchase
Order Revolving Loans”
together with the Receivable Revolving Loans, the “Revolving
Loans”)
to the
Companies from time to time during the Revolver Term which, in the aggregate
at
any time outstanding, will not exceed the lesser of (x)(I) the Capital
Availability Amount minus (II) the Reserves minus (III) the aggregate
outstanding principal balance of the Receivable Revolving Loans and (y) an
amount equal to (I) the Purchase Order Availability minus (II) the Reserves.
The
amount derived at any time from Section 2(a)(i)(B)(y)(I) minus 2(a)(i)(B)(y)(II)
shall be referred to as the “Purchase
Order Formula Amount”.
(C) The
Companies shall, jointly and severally, execute and deliver to Calliope on
the
Closing Date the Secured Revolving Note and the Secured Convertible Term Note.
The Companies hereby each acknowledge and agree that Calliope’s obligation to
purchase the Secured Revolving Note and the Secured Convertible Term Note from
the Companies on the Closing Date shall be contingent upon the satisfaction
(or
waiver by Calliope in its sole discretion) of the items and matters set forth
in
the closing checklist provided by Calliope to the Companies on or prior to
the
Closing Date. The Companies hereby each further acknowledge and agree that,
immediately prior to each borrowing hereunder and immediately after giving
effect thereto, the Companies shall be deemed to have certified to Calliope
that
at the time of each such proposed borrowing and also after giving effect thereto
(i) there shall exist no Event of Default, (ii) all representations, warranties
and covenants made by the Companies in connection with this Agreement and the
Ancillary Agreements are true, correct and complete and (iii) all of each
Company’s and its respective Subsidiaries’ covenant requirements under this
Agreement and the Ancillary Agreements have been met. The Companies hereby
agree
to provide a certificate confirming the foregoing concurrently with each request
for a borrowing hereunder.
2
(ii) Notwithstanding
the limitations set forth above, if requested by any Company, Calliope retains
the right to lend to such Company from time to time such amounts in excess
of
such limitations as Calliope may determine in its sole discretion. In connection
with each such request by one or more Companies, the Companies shall be deemed
to have certified, as of the time of such proposed borrowing and immediately
after giving effect thereto, to the satisfaction of all Overadvance Conditions.
For purposes hereof, “Overadvance
Conditions”
means
(i) no Event of Default shall exist and be continuing as of such date; (ii)
all
representations, warranties and covenants made by the Companies in connection
with the Security Agreement and the Ancillary Agreements shall be true, correct
and complete as of such date; and (iii) the Companies and their respective
Subsidiaries shall have taken all action necessary to grant Calliope “control”
over all of the Companies’ and their respective Subsidiaries’ Deposit Accounts
(the “Control
Accounts”),
with
any agreements establishing “control” to be in form and substance satisfactory
to Calliope. “Control”
over
such Control Accounts shall be released upon the indefeasible repayment in
full
and termination of the Overadvance (together with all accrued interest and
fees
which remain unpaid in respect thereof). The Companies hereby agree to provide
a
certificate confirming the satisfaction of the Overadvance Conditions
concurrently with the request for same.
(iii) The
Companies acknowledge that, in the exercise of its reasonable credit judgment,
Calliope may increase the advance percentages used in determining Accounts
Availability and may decrease the advance percentages used in determining
Accounts Availability for reasons relating to either an increase in dilution
or
other deterioration of the Accounts, in each case as determined by Calliope
in
its reasonable discretion. Each of the Companies hereby consent to any such
increases or decreases which may limit or restrict advances requested by the
Companies.
(iv) If
any
interest, fees, costs or charges payable to Calliope hereunder are not paid
when
due, each of the Companies shall thereby be deemed to have requested, and
Calliope is hereby authorized at its discretion to make and charge to the
Companies’ account, a Revolving Loan as of such date in an amount equal to such
unpaid interest, fees, costs or charges.
(v) If
any
Company at any time fails to perform or observe any of the covenants contained
in this Agreement or any Ancillary Agreement, Calliope may, but need not,
perform or observe such covenant on behalf and in the name, place and stead
of
such Company (or, at Calliope’s option, in Calliope’s name) and may, but need
not, take any and all other actions which Calliope may deem necessary to cure
or
correct such failure (including the payment of taxes, the satisfaction of Liens,
the performance of obligations owed to Account Debtors, lessors or other
obligors, the procurement and maintenance of insurance, the execution of
assignments, security agreements and financing statements, and the endorsement
of instruments). The amount of all monies expended and all costs and reasonable
expenses (including attorneys’ fees and legal expenses) incurred by Calliope in
connection with or as a result of the performance or observance of such
agreements or the taking of such action by Calliope shall be charged to the
Companies’ account as a Revolving Loan
and
added to the Obligations. To facilitate Calliope’s performance or observance of
such covenants by each Company, each Company hereby irrevocably appoints
Calliope, or Calliope’s delegate, acting alone, as such Company’s attorney in
fact (which appointment is coupled with an interest) with the right (but not
the
duty) from time to time to create, prepare, complete, execute, deliver, endorse
or file in the name and on behalf of such Company any and all instruments,
documents, assignments, security agreements, financing statements, applications
for insurance and other agreements and writings required to be obtained,
executed, delivered or endorsed by such Company.
3
(vi) Calliope
will account to Company Agent monthly with a statement of all Loans and other
advances, charges and payments made pursuant to this Agreement, and such account
rendered by Calliope shall be deemed final, binding and conclusive unless
Calliope is notified by Company Agent in writing to the contrary within thirty
(30) days of the date each account was rendered specifying the item or items
to
which objection is made.
(vii) During
the Revolver Term, the Companies may borrow, prepay and reborrow Revolving
Loans
in accordance with the terms and conditions hereof.
(viii) If
any
Eligible Account or any Eligible Credit Insured Account is not paid by the
Account Debtor within ninety (90) days after the date that such Eligible Account
or such Eligible Credit Insured Account, as applicable, was invoiced or if
any
Account Debtor asserts a deduction, dispute, contingency, set-off, or
counterclaim with respect to any Eligible Account or any Eligible Credit Insured
Account, (a “Delinquent
Account”),
the
Companies shall jointly and severally (i) reimburse Calliope for the amount
of
the Receivable Revolving Loans made with respect to such Delinquent Account
plus
an adjustment fee in an amount equal to one-half of one percent (0.50%) of
the
gross face amount of such Delinquent Account or (ii) immediately replace such
Delinquent Account with an otherwise Eligible Account or Eligible Credit Insured
Account.
(ix) If
the
Purchase Order Price set forth in any Eligible Purchase Order is not paid by
the
Approved Leasing Company within the lesser of (A) thirty (30) days of the date
the Products set forth in such Eligible Purchase Order are shipped to the
applicable Golf Course Customer and (B) the date the applicable Golf Course
Customer rejects the Products delivered pursuant to such Purchase Order (a
“Delinquent
Purchase Order”),
the
Companies shall jointly and severally reimburse Calliope for the amount of
the
Purchase Order Revolving Loan made with respect to such Delinquent Purchase
Order plus an adjustment fee in an amount equal to one half of one percent
(0.50%) of the Purchase Price set forth in such Delinquent Purchase
Order.
(b) Term
Loan.
Subject
to the terms and conditions set forth herein and in the Ancillary Agreements,
Calliope shall make a term loan (the “Term
Loan”)
to
Company Agent (for the benefit of Companies) in an aggregate amount equal to
$4,000,000. The Term Loan shall be advanced on the Closing Date and shall be,
with respect to principal, payable in consecutive monthly installments of
principal commencing on September 1, 2008 and on the first day of each month
thereafter, subject to acceleration upon the occurrence of an Event of Default
or termination of this Agreement. The Term Loan shall be evidenced by the
Secured Convertible Term Note.
4
3. Repayment
of the Loans.
The
Companies (a) may prepay the Obligations from time to time in accordance with
the terms and provisions of the Notes (and Section 17 hereof if such prepayment
is due to a termination of this Agreement); (b) shall repay on the expiration
of
the Term Loan Term (i) the then aggregate outstanding principal balance of
the
Term Loan together with accrued and unpaid interest, fees and charges and:
(ii)
all other amounts owed Calliope under the Secured Convertible Term Note; (c)
shall repay on the expiration of the Revolver Term (i) the then aggregate
outstanding principal balance of the Revolving Loans together with accrued
and
unpaid interest, fees and charges and; (ii) all other Obligations in respect
of
the Revolving Loans owed Calliope under this Agreement and the Ancillary
Agreements; (c) subject to Section 2(a)(ii), shall repay on any day on which
the
then aggregate outstanding principal balance of the Receivable Revolving Loans
are in excess of the Receivable Formula Amount at such time, Receivable Loans
in
an amount equal to such excess; and (d) subject to Section 2(a)(ii), shall
repay
on any day on which the then aggregate outstanding principal balance of the
Purchase Order Revolving Loans are in excess of the Purchase Order Formula
Amount at such time, Purchase Order Revolving Loans in an amount equal to such
excess. Any payments of principal, interest, fees or any other amounts payable
hereunder or under any Ancillary Agreement shall be made prior to 12:00 noon
(New York time) on the due date thereof in immediately available
funds.
4. Procedure
for Revolving Loans.
Company
Agent may by written notice request a borrowing of Revolving Loans prior to
12:00 noon (New York time) on the Business Day of its request to incur, on
the
next Business Day, a Revolving Loan. Together with each request for a Revolving
Loan (or at such other intervals as Calliope may request), Company Agent shall
deliver to Calliope a Borrowing Base Certificate in the form of Exhibit
B
attached
hereto, which shall be certified as true and correct by the Chief Executive
Officer or Chief Financial Officer of Company Agent together with all supporting
documentation relating thereto. All Revolving Loans shall be disbursed from
whichever office or other place Calliope may designate from time to time and
shall be charged to the Companies’ account on Calliope’s books. The proceeds of
each Revolving Loan made by Calliope shall be made available to Company Agent
on
the Business Day following the Business Day so requested in accordance with
the
terms of this Section 4 by way of credit to the applicable Company’s operating
account maintained with such bank as Company Agent designated to Calliope.
Any
and all Obligations due and owing hereunder may be charged to the Companies’
account and shall constitute Revolving Loans.
5. Interest
and Payments.
(a) Interest.
(i) Except
as
modified by Section 5(a)(iii) below, the Companies shall jointly and severally
pay interest at the Receivable Loan Contract Rate or Contract Rate, as
applicable, on the unpaid principal balance of each Loan until such time as
such
Loan is collected in full in good funds in dollars of the United States of
America.
(ii) Interest
and payments shall be computed on the basis of actual days elapsed in a year
of
360 days. At Calliope’s option, Calliope may charge the Companies’ account for
said interest.
5
(iii) Effective
upon the occurrence of any Event of Default and for so long as any Event of
Default shall be continuing, the Receivable Loan Contract Rate and Contract
Rate
shall automatically be increased as set forth in the Notes (such increased
rate,
the “Default
Rate”),
and
all outstanding Obligations, including unpaid interest, shall continue to accrue
interest from the date of such Event of Default at the Default Rate applicable
to such Obligations.
(iv) In
no
event shall the aggregate interest payable hereunder or under any Note exceed
the maximum rate permitted under any applicable law or regulation, as in effect
from time to time (the “Maximum
Legal Rate”),
and
if any provision of this Agreement or any Ancillary Agreement is in
contravention of any such law or regulation, interest payable under this
Agreement and each Ancillary Agreement shall be computed on the basis of the
Maximum Legal Rate (so that such interest will not exceed the Maximum Legal
Rate).
(v) The
Companies shall jointly and severally pay principal, interest and all other
amounts payable hereunder, or under any Ancillary Agreement, without any
deduction whatsoever, including any deduction for any set-off or
counterclaim.
(b) Payment;
Certain Closing Conditions.
(i) Payment.
Upon
execution of this Agreement by each Company and Calliope, the Companies shall
jointly and severally pay to Laurus Capital Management, LLC, the investment
manager of Calliope (“LCM”),
a
non-refundable payment in an amount equal to $315,000, which payment is intended
to defray certain of LCM’s due diligence, legal and other expenses incurred in
connection with the entering into of this Agreement and the Ancillary Agreements
and all related matters. All amounts required to be paid under this Section
5(b)(i) will be paid on the Closing Date from the proceeds of the initial Loans
made hereunder.
(ii) Overadvance
Payment.
Without
affecting Calliope’s rights hereunder in the event the Revolving Loans exceed
the Formula Amount (each such event, an “Overadvance”),
all
such Overadvances shall bear additional interest at a rate equal to one percent
(1%) per month of the amount of such Overadvances for all times such amounts
shall be in excess of the Formula Amount. All amounts that are incurred pursuant
to this Section 5(b)(ii) shall be due and payable by the Companies monthly,
in
arrears, on the first Business Day of each calendar month and upon expiration
of
the Revolver Term.
(iii) Purchase
Order Revolving Loan Fee.
Contemporaneously with the making of each Purchase Order Revolving Loan, the
Companies shall jointly and severally pay to Calliope a non-refundable fee
in an
amount equal to one percent (1.0%) of the principal amount of such Purchase
Order Revolving Loan.
(iv) Expenses.
The
Companies shall jointly and severally reimburse Calliope for its expenses
(including reasonable legal fees and expenses) incurred in connection with
the
preparation and negotiation of this Agreement and the Ancillary Agreements,
and
expenses incurred in connection with Calliope’s due diligence review of each
Company and its Subsidiaries and all related matters. Amounts required to be
paid under this Section 5(b)(iv) will be paid on the Closing Date from the
proceeds of the initial Loans made hereunder and shall not exceed
(a) $32,000 for expenses relating to the due diligence referred to in this
Section 5(b)(iv), plus (b) the cost of all third party appraisals and
extraordinary diligence deemed advisable or prudent by Calliope, plus
(c) $28,000 for structuring fees, plus (d) the reasonable legal fees
and expenses of Loeb & Loeb LLP. The Companies have previously paid a good
faith deposit of $18,000 to Calliope, which shall be credited toward the
Companies’ obligations to reimburse Calliope hereunder.
6
(v) Financial
Information Default.
Without
affecting Calliope’s other rights and remedies, in the event any Company fails
to deliver the financial information required by Section 11 on or before the
date required by this Agreement, the Companies shall jointly and severally
pay
Calliope an aggregate fee in the amount of $250.00 per week (or portion thereof)
for each such failure until such failure is cured to Calliope’s satisfaction or
waived in writing by Calliope. All amounts that are incurred pursuant to this
Section 5(b)(v) shall be due and payable upon receipt by the Companies of an
invoice from Calliope for such amounts, which shall be paid monthly, in arrears,
on the first business of each calendar month and upon expiration of the
Term.
6. Security
Interest.
(a) To
secure
the prompt payment to Calliope of the Obligations, each Company hereby assigns,
pledges and grants to Calliope a continuing security interest in and Lien upon
all of the Collateral. All of each Company’s Books and Records relating to the
Collateral shall, until delivered to or removed by Calliope, be kept by such
Company in trust for Calliope until all Obligations have been paid in full.
Each
confirmatory assignment schedule or other form of assignment hereafter executed
by each Company shall be deemed to include the foregoing grant, whether or
not
the same appears therein.
(b) Each
Company hereby (i) authorizes Calliope to file any financing statements,
continuation statements or amendments thereto that (x) indicate the Collateral
(1) as all assets and personal property of such Company or words of similar
effect, regardless of whether any particular asset comprised in the Collateral
falls within the scope of Article 9 of the UCC of the applicable jurisdiction,
or (2) as being of an equal or lesser scope or with greater detail, and (y)
contain any other information required by Part 5 of Article 9 of the UCC for
the
sufficiency or filing office acceptance of any financing statement, continuation
statement or amendment and (ii) ratifies its authorization for Calliope to
have
filed any initial financial statements, or amendments thereto if filed prior
to
the date hereof. Each Company acknowledges that it is not authorized to file
any
financing statement or amendment or termination statement with respect to any
financing statement without the prior written consent of Calliope and agrees
that it will not do so without the prior written consent of Calliope, subject
to
such Company’s rights under Section 9-509(d)(2) of the UCC.
(c) Each
Company hereby grants to Calliope an irrevocable, non-exclusive license
(exercisable upon the termination of this Agreement due to an occurrence and
during the continuance of an Event of Default without payment of royalty or
other compensation to such Company) to use, transfer, license or sublicense
any
Intellectual Property now owned, licensed to, or hereafter acquired by such
Company, and wherever the same may be located, and including in such license
access to all media in which any of the licensed items may be recorded or stored
and to all computer and automatic machinery software and programs used for
the
compilation or printout thereof, and represents, promises and agrees that any
such license or sublicense is not and will not be in conflict with the
contractual or commercial rights of any third Person; provided, that such
license will terminate on the termination of this Agreement and the payment
in
full of all Obligations.
7
7. Representations,
Warranties and Covenants Concerning the Collateral.
Each
Company represents, warrants (each of which such representations and warranties
shall be deemed repeated upon the making of each request for a Revolving Loan
and made as of the time of each and every Revolving Loan hereunder) and
covenants as follows:
(a) all
of
the Collateral (i) is owned by it free and clear of all Liens (including any
claims of infringement) except those in Calliope’s favor and Permitted Liens and
(ii) is not subject to any agreement prohibiting the granting of a Lien or
requiring notice of or consent to the granting of a Lien.
(b) it
shall
not encumber, mortgage, pledge, assign or grant any Lien in any Collateral
or
any other assets to anyone other than Calliope and except for Permitted
Liens.
(c) the
Liens
granted pursuant to this Agreement, upon due completion of the filings of UCC-1
financing statements in respect of each grantor of such Liens in the applicable
filing offices of the states of organization of such grantor and the completion
of the other filings and actions listed on Schedule 7(c) (which, in the case
of
all filings and other documents referred to in said Schedule, have been
delivered to Calliope in duly executed form) constitute valid perfected security
interests in all of the Collateral in favor of Calliope as security for the
prompt and complete payment and performance of the Obligations, enforceable
in
accordance with the terms hereof against any and all of its creditors and
purchasers and such security interest is prior to all other Liens in existence
on the date hereof.
(d) no
effective security agreement, mortgage, deed of trust, financing statement,
equivalent security or Lien instrument or continuation statement covering all
or
any part of the Collateral is or will be on file or of record in any public
office, except those relating to Permitted Liens.
(e) it
shall
not dispose of any of the Collateral whether by sale, lease or otherwise except
for the sale of Inventory in the ordinary course of business and for the
disposition or transfer in the ordinary course of business during any fiscal
year of obsolete and worn-out Equipment having an aggregate fair market value
of
not more than $25,000 and only to the extent that (i) the proceeds of any such
disposition are used to acquire replacement Equipment which is subject to
Calliope’s first priority security interest or are used to repay Loans or to pay
general corporate expenses, or (ii) following the occurrence of an Event of
Default which continues to exist the proceeds of which are remitted to Calliope
to be held as cash collateral for the Obligations.
(f) it
shall
defend the right, title and interest of Calliope in and to the Collateral
against the claims and demands of all Persons whomsoever, and take such actions,
including (i) all actions necessary to grant Calliope “control” of any
Investment Property, Deposit Accounts, Letter-of-Credit Rights or electronic
Chattel Paper owned by it, with any agreements establishing control to be in
form and substance satisfactory to Calliope, (ii) the prompt (but in no event
later than five (5) Business Days following Calliope’s request therefor)
delivery to Calliope of all original Instruments, Chattel Paper, negotiable
Documents and certificated Stock owned by it (in each case, accompanied by
stock
powers, allonges or other instruments of transfer executed in blank), (iii)
notification of Calliope’s interest in Collateral at Calliope’s request, and
(iv) the institution of litigation against third parties as shall be prudent
in
order to protect and preserve its and/or Calliope’s respective and several
interests in the Collateral.
8
(g) it
shall
promptly, and in any event within five (5) Business Days after the same is
acquired by it, notify Calliope of any commercial tort claim (as defined in
the
UCC) acquired by it and unless otherwise consented by Calliope, it shall enter
into a supplement to this Agreement granting to Calliope a Lien in such
commercial tort claim.
(h) it
shall
place notations upon its Books and Records and any of its financial statements
to disclose Calliope’s Lien in the Collateral.
(i) if
it
retains possession of any Chattel Paper or Instrument with Calliope’s consent,
upon Calliope’s request such Chattel Paper and Instruments shall be marked with
the following legend: “This writing and obligations evidenced or secured hereby
are subject to the security interest of Calliope Capital Corporation.”
Notwithstanding the foregoing, upon the reasonable request of Calliope, such
Chattel Paper and Instruments shall be delivered to Calliope.
(j) it
shall
perform in a reasonable time all other steps requested by Calliope to create
and
maintain in Calliope’s favor a valid perfected first Lien in all Collateral
subject only to Permitted Liens.
(k) it
shall
notify Calliope promptly and in any event within three (3) Business Days after
obtaining knowledge thereof (i) of any event or circumstance that, to its
knowledge, would cause Calliope to consider any then existing Account as no
longer constituting an Eligible Account or an Eligible Credit Insured Account;
(ii) of any material delay in its performance of any of its obligations to
any
Account Debtor; (iii) of any assertion by any Account Debtor of any material
claims, offsets or counterclaims; (iv) of any allowances, credits and/or monies
granted by it to any Account Debtor; (v) of all material adverse information
relating to the financial condition of an Account Debtor; (vi) of any material
return of goods; and (vii) of any loss, damage or destruction of any of the
Collateral.
(l) all
Eligible Accounts and Eligible Credit Insured Accounts (i) represent complete
bona fide transactions which require no further act under any circumstances
on
its part to make such Accounts payable by the Account Debtors, (ii) are not
subject to any present, future contingent offsets or counterclaims, and (iii)
do
not represent xxxx and hold sales, consignment sales, guaranteed sales, sale
or
return or other similar understandings or obligations of any Affiliate or
Subsidiary of such Company. It has not made, nor will it make, any agreement
with any Account Debtor for any extension of time for the payment of any
Account, any compromise or settlement for less than the full amount thereof,
any
release of any Account Debtor from liability therefor, or any deduction
therefrom except a discount or allowance for prompt or early payment allowed
by
it in the ordinary course of its business consistent with historical practice
and as previously disclosed to Calliope in writing.
9
(m) it
shall
keep and maintain its Equipment in good operating condition, except for ordinary
wear and tear, and shall make all necessary repairs and replacements thereof
so
that the value and operating efficiency shall at all times be maintained and
preserved. It shall not permit any such items to become a Fixture to real estate
or accessions to other personal property.
(n) it
shall
maintain and keep all of its Books and Records concerning the Collateral at
its
executive offices listed in Schedule
12(aa).
(o) it
shall
maintain and keep the tangible Collateral at the addresses listed in
Schedule
12(aa),
provided, that it may change such locations or open a new location, provided
that it provides Calliope at least thirty (30) days prior written notice of
such
changes or new location and (ii) prior to such change or opening of a new
location where Collateral having a value of more than $50,000 will be located,
it executes and delivers to Calliope such agreements deemed reasonably necessary
or prudent by Calliope, including landlord agreements, mortgagee agreements
and
warehouse agreements, each in form and substance satisfactory to Calliope,
to
adequately protect and maintain Calliope’s security interest in such
Collateral.
(p) Schedule
7(p)
lists
all banks and other financial institutions at which it maintains deposits and/or
other accounts, and such Schedule correctly identifies the name, address and
telephone number of each such depository, the name in which the account is
held,
a description of the purpose of the account, and the complete account number.
It
shall not establish any depository or other bank account with any financial
institution (other than the accounts set forth on Schedule
7(p))
without
Calliope’s prior written consent.
8. Payment
of Accounts.
(a) Each
Company will irrevocably direct all of its present and future Account Debtors
and other Persons obligated to make payments constituting Collateral to make
such payments directly to the lockboxes maintained by such Company (the
“Lockboxes”)
with
M&I Bank or such other financial institution accepted by Calliope in writing
as may be selected by such Company (the “Lockbox
Bank”)
pursuant to the terms of the certain agreements among one or more Companies,
Calliope and/or the Lockbox Bank. On or prior to the Closing Date, each Company
shall and shall cause the Lockbox Bank to enter into all such documentation
acceptable to Calliope pursuant to which, among other things, the Lockbox Bank
agrees to: (a) sweep the Lockbox on a daily basis and deposit all checks
received therein to an account designated by Calliope in writing and (b) comply
only with the instructions or other directions of Calliope concerning the
Lockbox. All of each Company’s invoices, account statements and other written or
oral communications directing, instructing, demanding or requesting payment
of
any Account of any Company or any other amount constituting Collateral shall
conspicuously direct that all payments be made to the Lockbox or such other
address as Calliope may direct in writing. If, notwithstanding the instructions
to Account Debtors, any Company receives any payments, such Company shall
immediately remit such payments to Calliope in their original form with all
necessary endorsements. Until so remitted, such Company shall hold all such
payments in trust for and as the property of Calliope and shall not commingle
such payments with any of its other funds or property.
10
(b) At
Calliope’s election, following the occurrence of an Event of Default which is
continuing, Calliope may notify each Company’s Account Debtors of Calliope’s
security interest in the Accounts, collect them directly and charge the
collection costs and reasonable expenses thereof to Company’s and the Eligible
Subsidiaries joint and several account.
9. Collection
and Maintenance of Collateral.
(a) Calliope
may verify each Company’s Accounts from time to time, but not more than three
(3) times during the first three (3) fiscal quarters of any fiscal year, unless
an Event of Default has occurred and is continuing or Calliope believes that
such verification is necessary to preserve or protect the Collateral, utilizing
an audit control company or any other agent of Calliope.
(b) Proceeds
of Accounts received by Calliope will be deemed received on the Business Day
after Calliope’s receipt of such proceeds in good funds in dollars of the United
States of America to an account designated by Calliope. Any amount received
by
Calliope after 12:00 noon (New York time) on any Business Day shall be
deemed received on the next Business Day.
(c) As
Calliope receives the proceeds of Accounts of any Company, it shall
(i) apply such proceeds, as required, to amounts outstanding under the
Secured Revolving Note, and (ii) remit all such remaining proceeds (net of
interest, fees and other amounts then due and owing to Calliope hereunder)
to
Company Agent (for the benefit of the applicable Companies) upon request (but
no
more often than twice a week). Notwithstanding the foregoing, following the
occurrence and during the continuance of an Event of Default, Calliope, at
its
option, may apply such proceeds to the Obligations in such order as Calliope
shall elect.
10. Inspections
and Appraisals.
At all
times during normal business hours, Calliope, and/or any agent of Calliope
shall
have the right to (a) have access to, visit, inspect, review, evaluate and
make
physical verification and appraisals of each Company’s properties and the
Collateral, (b) inspect, audit and copy (or take originals if necessary) and
make extracts from each Company’s Books and Records, including management
letters prepared by the Accountants, and (c) discuss with each Company’s
directors, principal officers, and independent accountants, each Company’s
business, assets, liabilities, financial condition, results of operations and
business prospects. So long as no Default or Event of Default has occurred
and
is continuing, such inspection and appraisal rights shall be limited to once
per
fiscal quarter. Each Company will deliver to Calliope any instrument necessary
for Calliope to obtain records from any service bureau maintaining records
for
such Company. If any internally prepared financial information, including that
required under this Section is unsatisfactory in any manner to Calliope,
Calliope may request that the Accountants review the same.
11. Financial
Reporting.
Company
Agent will deliver, or cause to be delivered, to Calliope each of the following,
which shall be in form and detail acceptable to Calliope:
11
(a) As
soon
as available, and in any event within one hundred four (104) days after the
end
of each fiscal year of the Parent, each Company’s audited financial statements
with a report of independent certified public accountants of recognized standing
selected by the Parent and acceptable to Calliope (the “Accountants”),
which
annual financial statements shall be without qualification and shall include
each of the Parent’s and each of its Subsidiaries’ balance sheet as at the end
of such fiscal year and the related statements of each of the Parent’s and each
of its Subsidiaries’ income, retained earnings and cash flows for the fiscal
year then ended, prepared on a consolidating and consolidated basis to include
the Parent, each Subsidiary of the Parent and each of their respective
affiliates, all in reasonable detail and prepared in accordance with GAAP,
together with (i) if and when available, copies of any management letters
prepared by the Accountants; and (ii) a certificate of the Parent’s President,
Chief Executive Officer or Chief Financial Officer stating that such financial
statements have been prepared in accordance with GAAP and whether or not such
officer has knowledge of the occurrence of any Default or Event of Default
hereunder and, if so, stating in reasonable detail the facts with respect
thereto;
(b) As
soon
as available and in any event within fifty (50) days after the end of each
fiscal quarter that is not a fiscal year end of the Parent, an
unaudited/internal balance sheet and statements of income, retained earnings
and
cash flows of each of the Parent’s and each of its Subsidiaries’ as at the end
of and for such quarter and for the year to date period then ended, prepared
on
a consolidating and consolidated basis to include the Parent, each Subsidiary
of
the Parent and each of their respective affiliates, in reasonable detail and
stating in comparative form the figures for the corresponding date and periods
in the previous year, all prepared in accordance with GAAP, subject to year-end
adjustments and accompanied by a certificate of the Parent’s President, Chief
Executive Officer or Chief Financial Officer, stating (i) that such financial
statements have been prepared in accordance with GAAP, subject to year-end
audit
adjustments, and (ii) whether or not such officer has knowledge of the
occurrence of any Default or Event of Default hereunder not theretofore reported
and remedied and, if so, stating in reasonable detail the facts with respect
thereto;
(c) As
soon
as available and in any event within fifteen (15) days after the end of each
calendar month, an unaudited/internal balance sheet and statements of income,
retained earnings and cash flows of each of the Parent and its Subsidiaries
as
at the end of and for such month and for the year to date period then ended,
prepared on a consolidating and consolidated basis to include the Parent, each
Subsidiary of the Parent and each of their respective affiliates, in reasonable
detail and stating in comparative form the figures for the corresponding date
and periods in the previous year, all prepared in accordance with GAAP, subject
to year-end adjustments and accompanied by a certificate of the Parent’s
President, Chief Executive Officer or Chief Financial Officer, stating (i)
that
such financial statements have been prepared in accordance with GAAP, subject
to
year-end audit adjustments, and (ii) whether or not such officer has knowledge
of the occurrence of any Default or Event of Default hereunder not theretofore
reported and remedied and, if so, stating in reasonable detail the facts with
respect thereto;
(d) Within
fifteen (15) days after the end of each month (or more frequently if Calliope
so
requests), agings of each Company’s Accounts, unaudited trial balances and their
accounts payable and a calculation of each Company’s Accounts, Eligible
Accounts, Eligible Credit Insured Accounts and Eligible Purchase Orders,
provided, however, that if Calliope shall request the foregoing information
more
often than as set forth in the immediately preceding clause, each Company shall
have fifteen (15) days from each such request to comply with Calliope’s
demand;
12
(e) Promptly
after (i) the filing thereof, copies of the Parent’s most recent registration
statements and annual, quarterly, monthly or other regular reports which the
Parent files with the Securities and Exchange Commission (the “SEC”),
and
(ii) the issuance thereof, copies of such financial statements, reports and
proxy statements as the Parent shall send to its stockholders;
(f) Within
fifteen (15) days following the end of each month (or more frequently if
Calliope so requests), a list of unpaid Accounts relating to Purchase Order
Invoices as of the last day of the proceeding month; and
(g) Together
with each delivery of any financial statement pursuant to Section 11(a), 11(b)
or 11(c), a Compliance Certificate duly executed by the President, Chief
Executive Officer or Chief Financial Officer of the Parent that, among other
things, (i) shows in reasonable detail the calculations used in determining
the
Consolidated Leverage Ratio, (ii) demonstrates compliance with each financial
covenant contained in Section 13(x) that is tested at least on a quarterly
basis
and (iii) states that no Default or Event of Default is continuing as of the
date of delivery of such Compliance Certificate or, if a Default or Event of
Default is continuing, states the nature thereof and the action that the
Companies propose to take with respect thereto.
(h) The
Parent shall deliver, or cause the applicable Subsidiary of the Parent to
deliver, such other information as the Purchaser shall reasonably
request.
12. Additional
Representations and Warranties.
Each
Company hereby represents and warrants to Calliope as follows:
(a) Organization,
Good Standing and Qualification.
It and
each of its Subsidiaries is a corporation, partnership or limited liability
company, as the case may be, duly organized, validly existing and in good
standing under the laws of its jurisdiction of organization. It and each of
its
Subsidiaries has the corporate, limited liability company or partnership, as
the
case may be, power and authority to own and operate its properties and assets
and, insofar as it is or shall be a party thereto, to (i) execute and deliver
this Agreement and the Ancillary Agreements, (ii) to issue and sell the Notes
and the shares of Common Stock issuable upon conversion of the Secured
Convertible Term Note (the “Note
Shares”),
(iii)
to issue and sell the Warrants and the shares of Common Stock issuable upon
exercise of the Warrants (the “Warrant
Shares”),
and
to (iv) carry out the provisions of this Agreement and the Ancillary Agreements
and to carry on its business as presently conducted. It and each of its
Subsidiaries is duly qualified and is authorized to do business and is in good
standing as a foreign corporation, partnership or limited liability company,
as
the case may be, in all jurisdictions in which the nature or location of its
activities and of its properties (both owned and leased) makes such
qualification necessary, except for those jurisdictions in which failure to
do
so has not had, or could not reasonably be expected to have, individually or
in
the aggregate, a Material Adverse Effect.
13
(b) Subsidiaries.
Each of
its direct and indirect Subsidiaries, the direct owner of each such Subsidiary
and its percentage ownership thereof, is set forth on Schedule
12(b).
(c) Capitalization;
Voting Rights.
(i) The
authorized capital stock of the Parent, as of the date hereof consists of
210,000,000 shares, of which (A) 200,000,000 are shares of Common Stock, par
value $0.0001 per share, 46,276,946 shares of which are issued and outstanding
and (B) 10,000,000 are shares of preferred stock, none of which are issued
and
outstanding. The authorized, issued and outstanding capital stock of each
Subsidiary of each Company is set forth on Schedule
12(c).
(ii) Except
as
disclosed on Schedule
12(c),
other
than: (i) the shares reserved for issuance under the Parent’s stock option
plans; and (ii) shares which may be issued pursuant to this Agreement and the
Ancillary Agreements, there are no outstanding options, warrants, rights
(including conversion or preemptive rights and rights of first refusal), proxy
or stockholder agreements, or arrangements or agreements of any kind for the
purchase or acquisition from the Parent of any of its securities. Except as
disclosed on Schedule
12(c),
neither
the offer, issuance or sale of any of the Notes or the Warrants or the issuance
of any of the Note Shares or the Warrant Shares, nor the consummation of any
transaction contemplated hereby will result in a change in the price or number
of any securities of the Parent outstanding, under anti-dilution or other
similar provisions contained in or affecting any such securities.
(iii) All
issued and outstanding shares of the Parent’s Common Stock: (i) have been duly
authorized and validly issued and are fully paid and non-assessable; and
(ii) were issued in compliance with all applicable state and federal laws
concerning the issuance of securities.
(iv) The
rights, preferences, privileges and restrictions of the shares of the Common
Stock are as stated in the Parent’s Certificate of Incorporation (the
“Charter”).
The
Note Shares and the Warrant Shares have been duly and validly reserved for
issuance. When issued in compliance with the provisions of this Agreement and
the Parent’s Charter, the Securities will be validly issued, fully paid and
nonassessable, and will be free of any liens or encumbrances; provided,
however,
that
the Securities may be subject to restrictions on transfer under state and/or
federal securities laws as set forth herein or as otherwise required by such
laws at the time a transfer is proposed.
(d) Authorization;
Binding Obligations.
All
corporate, partnership or limited liability company, as the case may be, action
on its and its Subsidiaries’ part (including their respective officers and
directors) necessary for the authorization of this Agreement and the Ancillary
Agreements, the performance of all of its and its Subsidiaries’ obligations
hereunder and under the Ancillary Agreements on the Closing Date and, the
authorization, issuance and delivery of the Notes and the Warrant has been
taken
or will be taken prior to the Closing Date. This Agreement and the Ancillary
Agreements, when executed and delivered and to the extent it is a party thereto,
will be its and its Subsidiaries’ valid and binding obligations enforceable
against each such Person in accordance with their terms,
except:
14
(i) as
limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other laws of general application affecting enforcement of creditors’ rights;
and
(ii) general
principles of equity that restrict the availability of equitable or legal
remedies.
The
issuance of the Notes and the subsequent conversion of the Secured Convertible
Term Note into Note Shares are not and will not be subject to any preemptive
rights or rights of first refusal that have not been properly waived or complied
with. The issuance of the Warrants and the subsequent exercise of the Warrants
for Warrant Shares are not and will not be subject to any preemptive rights
or
rights of first refusal that have not been properly waived or complied
with.
(e) Liabilities;
Solvency.
(i) Neither
it nor any of its Subsidiaries has any liabilities, except current liabilities
incurred in the ordinary course of business and liabilities disclosed in any
Exchange Act Filings.
(ii) Both
before and after giving effect to (a) the Loans incurred on the Closing Date
or
such other date as Loans requested hereunder are made or incurred, (b) the
disbursement of the proceeds of, or the assumption of the liability in respect
of, such Loans pursuant to the instructions or agreement of any Company and
(c)
the payment and accrual of all transaction costs in connection with the
foregoing, each Company and each Subsidiary of each Company, is and will be,
Solvent.
(f) Agreements;
Action.
Except
as set forth on Schedule
12(f)
or as
disclosed in any Exchange Act Filings:
(i) There
are
no agreements, understandings, instruments, contracts, proposed transactions,
judgments, orders, writs or decrees to which it or any of its Subsidiaries
is a
party or to its knowledge by which it is bound which may involve: (i)
obligations (contingent or otherwise) of, or payments to, it or any of its
Subsidiaries in excess of $50,000 (other than obligations of, or payments to,
it
or any of its Subsidiaries arising from purchase or sale agreements entered
into
in the ordinary course of business); or (ii) the transfer or license of any
patent, copyright, trade secret or other proprietary right to or from it (other
than licenses arising from the purchase of “off the shelf” or other standard
products); or (iii) provisions restricting the development, manufacture or
distribution of its or any of its Subsidiaries’ products or services; or (iv)
indemnification by it or any of its Subsidiaries with respect to infringements
of proprietary rights.
(ii) Since
June 30, 2007 (the “Balance
Sheet Date”),
neither it nor any of its Subsidiaries has: (i) declared or paid any dividends,
or authorized or made any distribution upon or with respect to any class or
series of its capital stock; (ii) incurred any indebtedness for money borrowed
or any other liabilities (other than ordinary course obligations) individually
in excess of $50,000 or, in the case of indebtedness and/or liabilities
individually less than $50,000, in excess of $100,000 in the aggregate; (iii)
made any loans or advances to any Person not in excess, individually or in
the
aggregate, of $100,000, other than ordinary advances for travel expenses; or
(iv) sold, exchanged or otherwise disposed of any of its assets or rights,
other
than the sale of its Inventory or obsolete equipment in the ordinary course
of
business.
15
(iii) For
the
purposes of subsections (i) and (ii) of this Section 12(f), all indebtedness,
liabilities, agreements, understandings, instruments, contracts and proposed
transactions involving the same Person (including Persons it or any of its
applicable Subsidiaries has reason to believe are affiliated therewith or with
any Subsidiary thereof) shall be aggregated for the purpose of meeting the
individual minimum dollar amounts of such subsections.
(iv) the
Parent maintains disclosure controls and procedures (“Disclosure
Controls”)
designed to ensure that information required to be disclosed by the Parent
in
the reports that it files or submits under the Exchange Act is recorded,
processed, summarized, and reported, within the time periods specified in the
rules and forms of the SEC.
(v) The
Parent makes and keeps books, records, and accounts, that, in reasonable detail,
accurately and fairly reflect the transactions and dispositions of its assets.
It maintains internal control over financial reporting (“Financial
Reporting Controls”)
designed by, or under the supervision of, its principal executive and principal
financial officers, and effected by its board of directors, management, and
other personnel, to provide reasonable assurance regarding the reliability
of
financial reporting and the preparation of financial statements for external
purposes in accordance with GAAP, including that:
(1) transactions
are executed in accordance with management’s general or specific
authorization;
(2) unauthorized
acquisition, use, or disposition of the Parent’s assets that could have a
material effect on the financial statements are prevented or timely
detected;
(3) transactions
are recorded as necessary to permit preparation of financial statements in
accordance with GAAP, and that its receipts and expenditures are being made
only
in accordance with authorizations of the Parent’s management and board of
directors;
(4) transactions
are recorded as necessary to maintain accountability for assets;
and
(5) the
recorded accountability for assets is compared with the existing assets at
reasonable intervals, and appropriate action is taken with respect to any
differences.
(vi) There
is
no weakness in any of its Disclosure Controls or Financial Reporting Controls
that is required to be disclosed in any of the Exchange Act Filings, except
as
so disclosed.
(g) Obligations
to Related Parties.
Except
as set forth on Schedule
12(g),
neither
it nor any of its Subsidiaries has any obligations to their respective officers,
directors, stockholders or employees other than:
16
(i) for
payment of salary for services rendered and for bonus payments;
(ii) reimbursement
for reasonable expenses incurred on its or its Subsidiaries’
behalf;
(iii) for
other
standard employee benefits made generally available to all employees (including
stock option agreements outstanding under any stock option plan approved by
its
and its Subsidiaries’ Board of Directors, as applicable); and
(iv) obligations
listed in its and each of its Subsidiary’s financial statements or disclosed in
any of the Parent’s Exchange Act Filings.
Except
as
described above or set forth on Schedule
12(g),
none of
its officers, directors or, to the best of its knowledge, key employees or
stockholders, any of its Subsidiaries or any members of their immediate
families, are indebted to it or any of its Subsidiaries, individually or in
the
aggregate, in excess of $50,000 or have any direct or indirect ownership
interest in any Person with which it or any of its Subsidiaries is affiliated
or
with which it or any of its Subsidiaries has a business relationship, or any
Person which competes with it or any of its Subsidiaries, other than passive
investments in publicly traded companies (representing less than one percent
(1%) of such company) which may compete with it or any of its Subsidiaries.
Except as described above, none of its officers, directors or stockholders,
or
any member of their immediate families, is, directly or indirectly, interested
in any material contract with it or any of its Subsidiaries and no agreements,
understandings or proposed transactions are contemplated between it or any
of
its Subsidiaries and any such Person. Except as set forth on Schedule
12(g),
neither
it nor any of its Subsidiaries is a guarantor or indemnitor of any indebtedness
of any other Person.
(h) Changes.
Since
the Balance Sheet Date, except as disclosed in any Exchange Act Filing or in
any
Schedule to this Agreement or to any of the Ancillary Agreements, there has
not
been:
(i) any
change in its or any of its Subsidiaries’ business, assets, liabilities,
condition (financial or otherwise), properties, operations or prospects, which,
individually or in the aggregate, has had, or could reasonably be expected
to
have, a Material Adverse Effect;
(ii) any
resignation or termination of any of its or its Subsidiaries’ officers, key
employees or groups of employees;
(iii) any
material change, except in the ordinary course of business, in its or any of
its
Subsidiaries’ contingent obligations by way of guaranty, endorsement, indemnity,
warranty or otherwise;
(iv) any
damage, destruction or loss, whether or not covered by insurance, which has
had,
or could reasonably be expected to have, individually or in the aggregate,
a
Material Adverse Effect;
17
(v) any
waiver by it or any of its Subsidiaries of a valuable right or of a material
debt owed to it;
(vi) any
direct or indirect material loans made by it or any of its Subsidiaries to
any
of its or any of its Subsidiaries’ stockholders, employees, officers or
directors, other than advances made in the ordinary course of
business;
(vii) any
material change in any compensation arrangement or agreement with any employee,
officer, director or stockholder;
(viii) any
declaration or payment of any dividend or other distribution of its or any
of
its Subsidiaries’ assets;
(ix) any
labor
organization activity related to it or any of its Subsidiaries;
(x) any
debt,
obligation or liability incurred, assumed or guaranteed by it or any of its
Subsidiaries, except those for immaterial amounts and for current liabilities
incurred in the ordinary course of business;
(xi) any
sale,
assignment or transfer of any Intellectual Property or other intangible
assets;
(xii) any
change in any material agreement to which it or any of its Subsidiaries is
a
party or by which either it or any of its Subsidiaries is bound which, either
individually or in the aggregate, has had, or could reasonably be expected
to
have, individually or in the aggregate, a Material Adverse Effect;
(xiii) any
other
event or condition of any character that, either individually or in the
aggregate, has had, or could reasonably be expected to have, individually or
in
the aggregate, a Material Adverse Effect; or
(xiv) any
arrangement or commitment by it or any of its Subsidiaries to do any of the
acts
described in subsection (i) through (xiii) of this Section 12(h).
(i) Title
to Properties and Assets; Liens, Etc.
Except
as set forth on Schedule 12(i),
it and
each of its Subsidiaries has good and marketable title to their respective
properties and assets, and good title to its leasehold interests, in each case
subject to no Lien, other than Permitted Liens.
All
facilities, Equipment, Fixtures, vehicles and other properties owned, leased
or
used by it or any of its Subsidiaries are in good operating condition and repair
and are reasonably fit and usable for the purposes for which they are being
used. Except as set forth on Schedule
12(i),
it and
each of its Subsidiaries is in compliance with all material terms of each lease
to which it is a party or is otherwise bound.
18
(j) Intellectual
Property.
(i) It
and
each of its Subsidiaries owns or possesses sufficient legal rights to all
Intellectual Property necessary for their respective businesses as now conducted
and, to its knowledge as presently proposed to be conducted, without any known
infringement of the rights of others. There are no outstanding options, licenses
or agreements of any kind relating to its or any of its Subsidiary’s
Intellectual Property, nor is it or any of its Subsidiaries bound by or a party
to any options, licenses or agreements of any kind with respect to the
Intellectual Property of any other Person other than such licenses or agreements
arising from the purchase of “off the shelf” or standard products.
(ii) Neither
it nor any of its Subsidiaries has received any communications alleging that
it
or any of its Subsidiaries has violated any of the Intellectual Property or
other proprietary rights of any other Person, nor is it or any of its
Subsidiaries aware of any basis therefor.
(iii) Neither
it nor any of its Subsidiaries believes it is or will be necessary to utilize
any inventions, trade secrets or proprietary information of any of its employees
made prior to their employment by it or any of its Subsidiaries, except for
inventions, trade secrets or proprietary information that have been rightfully
assigned to it or any of its Subsidiaries.
(k) Compliance
with Other Instruments.
Neither
it nor any of its Subsidiaries is in violation or default of (x) any term of
its
Charter or Bylaws, or (y) any provision of any indebtedness, mortgage,
indenture, contract, agreement or instrument to which it is party or by which
it
is bound or of any judgment, decree, order or writ, which violation or default,
in the case of this clause (y), has had, or could reasonably be expected to
have, either individually or in the aggregate, a Material Adverse Effect. The
execution, delivery and performance of and compliance with this Agreement and
the Ancillary Agreements to which it is a party, and the issuance of the Notes
and the other Securities each pursuant hereto and thereto, will not, with or
without the passage of time or giving of notice, result in any such material
violation, or be in conflict with or constitute a default under any such term
or
provision, or result in the creation of any Lien upon any of its or any of
its
Subsidiary’s properties or assets or the suspension, revocation, impairment,
forfeiture or nonrenewal of any permit, license, authorization or approval
applicable to it or any of its Subsidiaries, their businesses or operations
or
any of their assets or properties.
(l) Litigation.
Except
as set forth on Schedule
12(l),
there
is no action, suit, proceeding or investigation pending or, to its knowledge,
currently threatened against it or any of its Subsidiaries that prevents it
or
any of its Subsidiaries from entering into this Agreement or the Ancillary
Agreements, or from consummating the transactions contemplated hereby or
thereby, or which has had, or could reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect, or could result
in
any change in its or any of its Subsidiaries’ current equity ownership, nor is
it aware that there is any basis to assert any of the foregoing. Neither it
nor
any of its Subsidiaries is a party to or subject to the provisions of any order,
writ, injunction, judgment or decree of any court or government agency or
instrumentality. There is no action, suit, proceeding or investigation by it
or
any of its Subsidiaries currently pending or which it or any of its Subsidiaries
intends to initiate.
19
(m) Tax
Returns and Payments.
It and
each of its Subsidiaries has timely filed all tax returns (federal, state and
local) required to be filed by it. All taxes shown to be due and payable on
such
returns, any assessments imposed, and all other taxes due and payable by it
and
each of its Subsidiaries on or before the Closing Date, have been paid or will
be paid prior to the time they become delinquent. Except as set forth on
Schedule
12(m),
neither
it nor any of its Subsidiaries has been advised:
(i) that
any
of its returns, federal, state or other, have been or are being audited as
of
the date hereof; or
(ii) of
any
adjustment, deficiency, assessment or court decision in respect of its federal,
state or other taxes.
Neither
it nor any of its Subsidiaries has any knowledge of any liability of any tax
to
be imposed upon its properties or assets as of the date of this Agreement that
is not adequately provided for.
(n) Employees.
Except
as set forth on Schedule
12(n),
neither
it nor any of its Subsidiaries has any collective bargaining agreements with
any
of its employees. There is no labor union organizing activity pending or, to
its
knowledge, threatened with respect to it or any of its Subsidiaries. Except
as
disclosed in the Exchange Act Filings or on Schedule
12(n),
neither
it nor any of its Subsidiaries is a party to or bound by any currently effective
employment contract, deferred compensation arrangement, bonus plan, incentive
plan, profit sharing plan, retirement agreement or other employee compensation
plan or agreement. To its knowledge, none of its or any of its Subsidiaries’
employees, nor any consultant with whom it or any of its Subsidiaries has
contracted, is in violation of any term of any employment contract, proprietary
information agreement or any other agreement relating to the right of any such
individual to be employed by, or to contract with, it or any of its Subsidiaries
because of the nature of the business to be conducted by it or any of its
Subsidiaries; and to its knowledge the continued employment by it and its
Subsidiaries of their present employees, and the performance of its and its
Subsidiaries contracts with its independent contractors, will not result in
any
such violation. Neither it nor any of its Subsidiaries is aware that any of
its
or any of its Subsidiaries’ employees is obligated under any contract (including
licenses, covenants or commitments of any nature) or other agreement, or subject
to any judgment, decree or order of any court or administrative agency that
would interfere with their duties to it or any of its Subsidiaries. Neither
it
nor any of its Subsidiaries has received any notice alleging that any such
violation has occurred. Except for employees who have a current effective
employment agreement with it or any of its Subsidiaries, none of its or any
of
its Subsidiaries’ employees has been granted the right to continued employment
by it or any of its Subsidiaries or to any material compensation following
termination of employment with it or any of its Subsidiaries. Except as set
forth on Schedule 12(n),
neither
it nor any of its Subsidiaries is aware that any officer, key employee or group
of employees intends to terminate his, her or their employment with it or any
of
its Subsidiaries, as applicable, nor does it or any of its Subsidiaries have
a
present intention to terminate the employment of any officer, key employee
or
group of employees.
20
(o) Registration
Rights and Voting Rights.
Except
as set forth on Schedule 12(o)
and
except as disclosed in Exchange Act Filings, neither it nor any of its
Subsidiaries is presently under any obligation, and neither it nor any of its
Subsidiaries has granted any rights, to register any of its or any of its
Subsidiaries’ presently outstanding securities or any of its securities that may
hereafter be issued. Except as set forth on Schedule 12(o)
and
except as disclosed in Exchange Act Filings, to its knowledge, none of its
or
any of its Subsidiaries’ stockholders has entered into any agreement with
respect to its or any of its Subsidiaries’ voting of equity
securities.
(p) Compliance
with Laws; Permits.
Neither
it nor any of its Subsidiaries is in violation of the Xxxxxxxx-Xxxxx Act of
2002
or any SEC related regulation or rule or any rule of the Principal Market
promulgated thereunder or any other applicable statute, rule, regulation, order
or restriction of any domestic or foreign government or any instrumentality
or
agency thereof in respect of the conduct of its business or the ownership of
its
properties which has had, or could reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect. No governmental
orders, permissions, consents, approvals or authorizations are required to
be
obtained and no registrations or declarations are required to be filed in
connection with the execution and delivery of this Agreement or any Ancillary
Agreement and the issuance of any of the Securities, except such as have been
duly and validly obtained or filed, or with respect to any filings that must
be
made after the Closing Date, as will be filed in a timely manner. It and each
of
its Subsidiaries has all material franchises, permits, licenses and any similar
authority necessary for the conduct of its business as now being conducted
by
it, the lack of which could, either individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.
(q) Environmental
and Safety Laws.
Neither
it nor any of its Subsidiaries is in violation of any applicable statute, law
or
regulation relating to the environment or occupational health and safety, and
to
its knowledge, no material expenditures are or will be required in order to
comply with any such existing statute, law or regulation. Except as set forth
on
Schedule
12(q),
no
Hazardous Materials (as defined below) are used or have been used, stored,
or
disposed of by it or any of its Subsidiaries or, to its knowledge, by any other
Person on any property owned, leased or used by it or any of its Subsidiaries.
For the purposes of the preceding sentence, “Hazardous
Materials”
shall
mean:
(i) materials
which are listed or otherwise defined as “hazardous” or “toxic” under any
applicable local, state, federal and/or foreign laws and regulations that govern
the existence and/or remedy of contamination on property, the protection of
the
environment from contamination, the control of hazardous wastes, or other
activities involving hazardous substances, including building materials;
and
(ii) any
petroleum products or nuclear materials.
(r) Valid
Offering.
Assuming the accuracy of the representations and warranties of Calliope
contained in this Agreement, the offer and issuance of the Securities will
be
exempt from the registration requirements of the Securities Act of 1933, as
amended (the “Securities
Act”),
and
will have been registered or qualified (or are exempt from registration and
qualification) under the registration, permit or qualification requirements
of
all applicable state securities laws.
21
(s) Full
Disclosure.
It and
each of its Subsidiaries has provided Calliope with all information requested
by
Calliope in connection with Calliope’s decision to enter into this Agreement.
Neither this Agreement, the Ancillary Agreements nor the exhibits and schedules
hereto and thereto nor any other document delivered by it or any of its
Subsidiaries to Calliope or its attorneys or agents in connection herewith
or
therewith or with the transactions contemplated hereby or thereby, contain
any
untrue statement of a material fact nor omit to state a material fact necessary
in order to make the statements contained herein or therein, in light of the
circumstances in which they are made, not misleading. Any financial projections
and other estimates provided to Calliope by it or any of its Subsidiaries were
prepared in good faith based on assumptions believed to be reasonable at the
time.
(t) Insurance.
It and
each of its Subsidiaries has general commercial, product liability, fire and
casualty insurance policies with coverages which it believes are customary
for
companies similarly situated to it and its Subsidiaries in the same or similar
business.
(u) SEC
Reports and Financial Statements.
Except
as set forth on Schedule 12(u),
it and
each of its Subsidiaries has filed all proxy statements, reports and other
documents required to be filed by it under the Exchange Act. The Parent has
furnished Calliope with copies of: (i) its Annual Report on Form 10-KSB for
its
fiscal year ended December 31, 2006; and (ii) its Quarterly Reports on Form
10-QSB for its fiscal quarters ended March 31, 2007 and June 30, 2007, and
the
Form 8-K filings which it has made during its fiscal year 2007 to date
(collectively, the “SEC
Reports”).
Except as set forth on Schedule
12(u),
each
SEC Report was, at the time of its filing, in substantial compliance with the
requirements of its respective form and none of the SEC Reports, nor the
financial statements (and the notes thereto) included in the SEC Reports, as
of
their respective filing dates, contained any untrue statement of a material
fact
or omitted to state a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they
were made, not misleading. Such financial statements have been prepared in
accordance with GAAP applied on a consistent basis during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the
notes thereto or (ii) in the case of unaudited interim statements, to the extent
they may not include footnotes or may be condensed) and fairly present in all
material respects the financial condition, the results of operations and cash
flows of the Parent and its Subsidiaries, on a consolidated basis, as of, and
for, the periods presented in each such SEC Report.
(v) Listing.
The
Parent’s Common Stock is listed or quoted, as applicable, on the Principal
Market and satisfies all requirements for the continuation of such listing
or
quotation, as applicable, and the Parent shall do all things necessary for
the
continuation of such listing or quotation, as applicable. The Parent has not
received any notice that its Common Stock will be delisted from, or no longer
quoted on, as applicable, the Principal Market or that its Common Stock does
not
meet all requirements for such listing or quotation, as
applicable.
22
(w) No
Integrated Offering.
Neither
it, nor any of its Subsidiaries nor any of its Affiliates, nor any Person acting
on its or their behalf, has directly or indirectly made any offers or sales
of
any security or solicited any offers to buy any security under circumstances
that would cause the offering of the Securities pursuant to this Agreement
or
any Ancillary Agreement to be integrated with prior offerings by it for purposes
of the Securities Act which would prevent it from issuing the Securities
pursuant to Rule 506 under the Securities Act, or any applicable
exchange-related stockholder approval provisions, nor will it or any of its
Affiliates or Subsidiaries take any action or steps that would cause the
offering of the Securities to be integrated with other offerings.
(x) Stop
Transfer.
The
Securities are restricted securities as of the date of this Agreement. Neither
it nor any of its Subsidiaries will issue any stop transfer order or other
order
impeding the sale and delivery of any of the Securities at such time as the
Securities are registered for public sale or an exemption from registration
is
available, except as required by state and federal securities laws.
(y) Dilution.
It
specifically acknowledges that the Parent’s obligation to issue the shares of
Common Stock upon conversion of the Secured Convertible Term Note and exercise
of the Warrants is binding upon the Parent and enforceable regardless of the
dilution such issuance may have on the ownership interests of other shareholders
of the Parent.
(z) Patriot
Act.
It
certifies that, to the best of its knowledge, neither it nor any of its
Subsidiaries has been designated, nor is or shall be owned or controlled, by
a
“suspected terrorist” as defined in Executive Order 13224. It hereby
acknowledges that Calliope seeks to comply with all applicable laws concerning
money laundering and related activities. In furtherance of those efforts, it
hereby represents, warrants and covenants that: (i) none of the cash or property
that it or any of its Subsidiaries will pay or will contribute to Calliope
has
been or shall be derived from, or related to, any activity that is deemed
criminal under United States law; and (ii) no contribution or payment by it
or
any of its Subsidiaries to Calliope, to the extent that they are within its
or
any such Subsidiary’s control shall cause Calliope to be in violation of the
United States Bank Secrecy Act, the United States International Money Laundering
Control Act of 1986 or the United States International Money Laundering
Abatement and Anti-Terrorist Financing Act of 2001. It shall promptly notify
Calliope if any of these representations, warranties and covenants ceases to
be
true and accurate regarding it or any of its Subsidiaries. It shall provide
Calliope with any additional information regarding it and each Subsidiary
thereof that Xxxxxxxx xxxxx necessary or convenient to ensure compliance with
all applicable laws concerning money laundering and similar activities. It
understands and agrees that if at any time it is discovered that any of the
foregoing representations, warranties and covenants are incorrect, or if
otherwise required by applicable law or regulation related to money laundering
or similar activities, Calliope may undertake appropriate actions to ensure
compliance with applicable law or regulation, including but not limited to
segregation and/or redemption of Calliope’s investment in it. It further
understands that Calliope may release confidential information about it and
its
Subsidiaries and, if applicable, any underlying beneficial owners, to proper
authorities if Calliope, in its sole discretion, determines that it is in the
best interests of Calliope in light of relevant rules and regulations under
the
laws set forth in subsection (ii) above.
23
(aa) Company
Name; Locations of Offices, Records and Collateral.
Schedule 12(aa)
sets
forth each Company’s name as it appears in official filings in the state of its
organization, the type of entity of each Company, the organizational
identification number issued by each Company’s state of organization or a
statement that no such number has been issued, each Company’s state of
organization, and the location of each Company’s chief executive office,
corporate offices, warehouses, other locations of Collateral and locations
where
records with respect to Collateral are kept (including in each case the county
of such locations) and, except as set forth in such Schedule
12(aa),
such
locations have not changed during the preceding twelve months. As of the Closing
Date, during the prior five years, except as set forth in Schedule
12(aa),
no
Company has been known as or conducted business in any other name (including
trade names). Each Company has only one state of organization.
(bb) ERISA.
Based
upon the Employee Retirement Income Security Act of 1974 (“ERISA”),
and
the regulations and published interpretations thereunder: (i) neither it nor
any
of its Subsidiaries has engaged in any Prohibited Transactions (as defined
in
Section 406 of ERISA and Section 4975 of the Code); (ii) it and each of its
Subsidiaries has met all applicable minimum funding requirements under Section
302 of ERISA in respect of its plans; (iii) neither it nor any of its
Subsidiaries has any knowledge of any event or occurrence which would cause
the
Pension Benefit Guaranty Corporation to institute proceedings under Title IV
of
ERISA to terminate any employee benefit plan(s); (iv) neither it nor any of
its
Subsidiaries has any fiduciary responsibility for investments with respect
to
any plan existing for the benefit of persons other than its or such Subsidiary’s
employees; and (v) neither it nor any of its Subsidiaries has withdrawn,
completely or partially, from any multi-employer pension plan so as to incur
liability under the Multiemployer Pension Plan Amendments Act of
1980.
(cc) Investor
First Refusal Rights.
All
Investor First Refusal Rights and all other similar rights granted to any Person
are as set forth on Schedule
12(cc)
attached
hereto. An RFO Notice (as defined in the SPA) has been sent by the Parent to
each Qualifying Investor (as defined in the SPA) in accordance and in compliance
with the terms of the SPA. Each Qualifying Investor has either waived in writing
its Investor First Refusal Rights with respect to the transactions contemplated
by this Agreement or waived such Investor First Refusal Rights as a result
of
such Qualifying Investor not electing to exercise such rights within the
requisite time period set forth in the SPA.
(dd) ProLink
UK.
ProLink
UK does not engage in any business of a material nature or own any
assets.
13. Covenants.
Each
Company, as applicable, covenants and agrees with Calliope as
follows:
(a) Stop-Orders.
The
Parent shall advise Calliope, promptly after it receives notice of issuance
by
the SEC, any state securities commission or any other regulatory authority
of
any stop order or of any order preventing or suspending any offering of any
securities of the Parent, or of the suspension of the qualification of the
Common Stock of the Parent for offering or sale in any jurisdiction, or the
initiation of any proceeding for any such purpose.
24
(b) Listing.
The
Parent shall promptly secure the listing or quotation, as applicable, of the
shares of Common Stock issuable upon conversion of the Secured Convertible
Term
Note and exercise of the Warrants on the Principal Market upon which shares
of
Common Stock are listed or quoted, as applicable, (subject to official notice
of
issuance) and shall maintain such listing or quotation, as applicable, so long
as any other shares of Common Stock shall be so listed or quoted, as applicable.
The Parent shall maintain the listing or quotation, as applicable, of its Common
Stock on the Principal Market, and will comply in all material respects with
the
Parent’s reporting, filing and other obligations under the bylaws or rules of
the National Association of Securities Dealers (“NASD”)
and
such exchanges, as applicable.
(c) Market
Regulations.
It
shall notify the SEC, NASD and applicable state authorities, in accordance
with
their requirements, of the transactions contemplated by this Agreement, and
shall take all other necessary action and proceedings as may be required and
permitted by applicable law, rule and regulation, for the legal and valid
issuance of the Securities to Calliope and promptly provide copies thereof
to
Calliope.
(d) Reporting
Requirements.
It
shall timely file with the SEC all reports required to be filed pursuant to
the
Exchange Act and refrain from terminating its status as an issuer required
by
the Exchange Act to file reports thereunder even if the Exchange Act or the
rules or regulations thereunder would permit such termination.
(e) Use
of
Funds.
It
shall use the proceeds of the Loans (i) to repay in full the Existing
Indebtedness and (ii) for general working capital purposes only.
(f) Access
to Facilities.
It
shall, and shall cause each of its Subsidiaries to, permit any representatives
designated by Calliope (or any successor of Calliope), upon reasonable notice
and during normal business hours, at Company’s expense and accompanied by a
representative of Company Agent (provided that (i) no such prior notice shall
be
required to be given and no such representative shall be required to accompany
Calliope in the event Calliope believes such access is necessary to preserve
or
protect the Collateral or following the occurrence and during the continuance
of
an Event of Default and (ii) such inspections and examinations shall be limited
to once per calendar quarter unless a Default or an Event of Default has
occurred and is continuing or Calliope believes such access is necessary to
preserve or protect the Collateral), to:
(i) visit
and
inspect any of its or any such Subsidiary’s properties;
(ii) examine
its or any such Subsidiary’s corporate and financial records (unless such
examination is not permitted by federal, state or local law or by contract)
and
make copies thereof or extracts therefrom; and
(iii) discuss
its or any such Subsidiary’s affairs, finances and accounts with its or any such
Subsidiary’s directors, officers and Accountants.
Notwithstanding
the foregoing, neither it nor any of its Subsidiaries shall provide any
material, non-public information to Calliope unless Calliope signs a
confidentiality agreement and otherwise complies with Regulation FD, under
the
federal securities laws.
25
(g) Taxes.
It
shall, and shall cause each of its Subsidiaries to, promptly pay and discharge,
or cause to be paid and discharged, when due and payable, all lawful taxes,
assessments and governmental charges or levies imposed upon it and its
Subsidiaries’ income, profits, property or business, as the case may be;
provided, however, that any such tax, assessment, charge or levy need not be
paid currently if (i) the validity thereof shall currently and diligently be
contested in good faith by appropriate proceedings, (ii) such tax, assessment,
charge or levy shall have no effect on the Lien priority of Calliope in the
Collateral, and (iii) if it and/or such Subsidiary, as applicable, shall have
set aside on its and/or such Subsidiary’s books adequate reserves with respect
thereto in accordance with GAAP; and provided, further, that it shall, and
shall
cause each of its Subsidiaries to, pay all such taxes, assessments, charges
or
levies forthwith upon the commencement of proceedings to foreclose any lien
which may have attached as security therefor.
(h) Insurance.
(i) It
shall
bear the full risk of loss from any loss of any nature whatsoever with respect
to the Collateral and it and each of its Subsidiaries will, jointly and
severally, bear the full risk of loss from any loss of any nature whatsoever
with respect to the assets pledged to Calliope as security for the Obligations.
Furthermore, it will insure or cause the Collateral to be insured in Calliope’s
name as an additional insured and lender loss payee, with an appropriate loss
payable endorsement in form and substance satisfactory to Calliope, against
loss
or damage by fire, flood, sprinkler leakage, theft, burglary, pilferage, loss
in
transit and other risks customarily insured against by companies in similar
business similarly situated as it and its Subsidiaries including but not limited
to workers compensation, public and product liability and business interruption,
and such other hazards as Calliope shall specify in amounts and under insurance
policies and bonds by insurers acceptable to Calliope and all premiums thereon
shall be paid by such Company and the policies delivered to Calliope. If any
such Company fails to obtain the insurance and in such amounts of coverage
as
otherwise required pursuant to this Section (h), Calliope may procure such
insurance and the cost thereof shall be promptly reimbursed by the Companies,
jointly and severally, and shall constitute Obligations.
(ii) No
Company’s insurance coverage shall be impaired or invalidated by any act or
neglect of any Company or any of its Subsidiaries and the insurer will provide
Calliope with no less than thirty (30) days notice prior of
cancellation;
(iii) Calliope,
in connection with its status as a lender loss payee, will be assigned at all
times to a first lien position until such time as all Calliope Obligations
have
been indefeasibly satisfied in full.
(i) Intellectual
Property.
It
shall, and shall cause each of its Subsidiaries to, maintain in full force
and
effect its corporate existence, rights and franchises and all licenses and
other
rights to use Intellectual Property owned or possessed by it and reasonably
deemed to be necessary to the conduct of its business.
(j) Properties.
It
shall, and shall cause each of its Subsidiaries to, keep its properties in
good
repair, working order and condition, reasonable wear and tear excepted, and
from
time to time make all needful and proper repairs, renewals, replacements,
additions and improvements thereto; and it shall, and shall cause each of its
Subsidiaries to, at all times comply with each provision of all leases to which
it is a party or under which it occupies property if the breach of such
provision could reasonably be expected to have a Material Adverse
Effect.
26
(k) Confidentiality.
It
shall not, and shall not permit any of its Subsidiaries to, disclose, and will
not include in any public announcement, the name of Calliope, unless expressly
agreed to by Calliope or unless and until such disclosure is required by law
or
applicable regulation, and then only to the extent of such requirement.
Notwithstanding the foregoing, each Company and its Subsidiaries may disclose
Calliope’s identity and the terms of this Agreement to its current and
prospective debt and equity financing sources.
(l) Required
Approvals.
It
shall not, and shall not permit any of its Subsidiaries to, without the prior
written consent of Calliope, (i) create, incur, assume or suffer to exist any
indebtedness (exclusive of trade debt) whether secured or unsecured other than
each Company’s indebtedness to Calliope and as set forth on Schedule 13(l)(i)
attached
hereto and made a part hereof; (ii) cancel any debt owing to it in excess of
$50,000 in the aggregate during any 12 month period; (iii) assume, guarantee,
endorse or otherwise become directly or contingently liable in connection with
any obligations of any other Person, except the endorsement of negotiable
instruments by it or its Subsidiaries for deposit or collection or similar
transactions in the ordinary course of business; (iv) directly or indirectly
declare, pay or make any dividend or distribution on any class of its Stock
except for dividends or distributions paid or made to the Parent on account
of
its ownership interest in its Subsidiaries, or apply any of its funds, property
or assets to the purchase, redemption or other retirement of any of its or
its
Subsidiaries’ Stock, or issue any preferred stock; (v) purchase or hold
beneficially any Stock or other securities or evidences of indebtedness of,
make
or permit to exist any loans or advances to, or make any investment or acquire
any interest whatsoever in, any other Person, including any partnership or
joint
venture, except (x) travel advances, (y) loans to its and its Subsidiaries’
officers and employees not exceeding at any one time an aggregate of $10,000,
and (z) loans to its existing Subsidiaries so long as such Subsidiaries are
designated as either a co-borrower hereunder or has entered into such guaranty
and security documentation required by Calliope, including, without limitation,
to grant to Calliope a first priority perfected security interest in
substantially all of such Subsidiary’s assets to secure the Obligations; (vi)
create or permit to exist any Subsidiary, other than any Subsidiary in existence
on the date hereof and listed in Schedule
12(b)
unless
such new Subsidiary is a wholly-owned Subsidiary and is designated by Calliope
as either a co-borrower or guarantor hereunder and such Subsidiary shall have
entered into all such documentation required by Calliope, including, without
limitation, to grant to Calliope a first priority perfected security interest
in
substantially all of such Subsidiary’s assets to secure the Obligations; (vii)
directly or indirectly, prepay any indebtedness (other than to Calliope and
in
the ordinary course of business), or repurchase, redeem, retire or otherwise
acquire any indebtedness (other than to Calliope and in the ordinary course
of
business) except to make scheduled payments of principal and interest thereof;
(viii) enter into any merger, consolidation or other reorganization with or
into
any other Person or acquire all or a portion of the assets or Stock of any
Person or permit any other Person to consolidate with or merge with it;
provided, however, such Company may enter into a merger, consolidation or other
reorganization so long as (1) Calliope has received at least thirty (30)
days written notice of such merger, consolidation or reorganization prior to
the
consummation thereof and, simultaneously with the consummation of such merger,
consolidation or reorganization, all of the Obligations are indefeasibly paid
in
full in cash and this Agreement is irrevocably terminated (“Permitted
Reorganization”)
or
(2) if, simultaneously with the consummation of such merger, consolidation
or reorganization, all of the Obligations are not indefeasibly paid in full
in
cash and this Agreement is not irrevocably terminated, each of the following
conditions have been satisfied to Calliope’s satisfaction: (A) such Company
or any other Company is the surviving entity of such merger, consolidation
or
reorganization, (B) no Event of Default shall exist immediately prior to
and after giving effect to such merger, consolidation or reorganization,
(C) such Company shall have provided Calliope copies of all documentation
relating to such merger, consolidation or reorganization, and (D) such
Company shall have provided Calliope with at least thirty (30) days prior
written notice of such merger, consolidation or reorganization prior to the
consummation thereof; (ix) materially change the nature of the business in
which
it is presently engaged; (x) become subject to (including, without limitation,
by way of amendment to or modification of) any agreement or instrument which
by
its terms would (under any circumstances) restrict its or any of its
Subsidiaries’ right to perform the provisions of this Agreement or any of the
Ancillary Agreements; (xi) change its fiscal year or make any changes in
accounting treatment and reporting practices without prior written notice to
Calliope except as required by GAAP or in the tax reporting treatment or except
as required by law; (xii) enter into any transaction with any employee, director
or Affiliate, except in the ordinary course on arms-length terms; (xiii) xxxx
Accounts under any name except the present name of such Company; or (xiv) sell,
lease, transfer or otherwise dispose of any of its properties or assets, or
any
of the properties or assets of its Subsidiaries, except for (1) sales, leases,
transfer or dispositions by any Company to any other Company, (2) the sale
of
Inventory in the ordinary course of business and (3) the disposition or transfer
in the ordinary course of business during any fiscal year of obsolete and
worn-out Equipment and only to the extent that (x) the proceeds of any such
disposition are used to acquire replacement Equipment which is subject to
Calliope’s first priority security interest or are used to repay Loans or to pay
general corporate expenses, or (y) following the occurrence of an Event of
Default which continues to exist, the proceeds of which are remitted to Calliope
to be held as cash collateral for the Obligations; provided, however, that
the
Companies may, upon no less than thirty (30) days prior written notice to
Calliope, sell, lease, transfer or otherwise dispose of all or substantially
all
of their properties or assets without the consent of Calliope if the Obligations
are indefeasibly paid in full in cash and this Agreement is irrevocably
terminated prior to or simultaneously with the consummation of any such sale,
lease, transfer or other disposition (“Permitted
Disposition”).
A
Permitted Reorganization or a Permitted Disposition shall not constitute a
Default or Event of Default under the Agreement or the Ancillary
Agreements.
27
(m) Reissuance
of Securities.
The
Parent shall reissue certificates representing the Securities without the
legends set forth in Section 39 below at such time as:
(i) the
holder thereof is permitted to dispose of such Securities pursuant to Rule
144(k) under the Securities Act; or
(ii) upon
resale subject to an effective registration statement after such Securities
are
registered under the Securities Act.
The
Parent agrees to cooperate with Calliope in connection with all resales pursuant
to Rule 144(d) and Rule 144(k) and provide legal opinions necessary to allow
such resales provided the Parent and its counsel receive reasonably requested
representations from Calliope and broker, if any.
28
(n) Opinion.
On the
Closing Date, it shall deliver to Calliope an opinion acceptable to Calliope
from each Company’s legal counsel. Each Company will provide, at the Companies’
joint and several expense, such other legal opinions in the future as are
reasonably necessary for the resale and conversion of the Secured Convertible
Term Note and the exercise of the Warrants.
(o) Legal
Name, etc.
It
shall not, without providing Calliope with 30 days prior written notice, change
(i) its name as it appears in the official filings in the state of its
organization, (ii) the type of legal entity it is, (iii) its organization
identification number, if any, issued by its state of organization, (iv) its
state of organization or (v) amend its certificate of incorporation, by-laws
or
other organizational document.
(p) Compliance
with Laws.
The
operation of each of its and each of its Subsidiaries’ business is and shall
continue to be in compliance in all material respects with all applicable
federal, state and local laws, rules and ordinances, including to all laws,
rules, regulations and orders relating to taxes, payment and withholding of
payroll taxes, employer and employee contributions and similar items,
securities, employee retirement and welfare benefits, employee health and safety
and environmental matters.
(q) Notices.
It and
each of its Subsidiaries shall promptly inform Calliope in writing of: (i)
the
commencement of all proceedings and investigations by or before and/or the
receipt of any notices from, any governmental or nongovernmental body and all
actions and proceedings in any court or before any arbitrator against or in
any
way concerning any event which could reasonably be expected to have singly
or in
the aggregate, a Material Adverse Effect; (ii) any change which has had, or
could reasonably be expected to have, a Material Adverse Effect; (iii) any
Event
of Default or Default; and (iv) any default or any event which with the passage
of time or giving of notice or both would constitute a default under any
agreement for the payment of money to which it or any of its Subsidiaries is
a
party or by which it or any of its Subsidiaries or any of its or any such
Subsidiary’s properties may be bound the breach of which would have a Material
Adverse Effect.
(r) Margin
Stock.
It
shall not permit any of the proceeds of the Loans made hereunder to be used
directly or indirectly to “purchase” or “carry” “margin stock” or to repay
indebtedness incurred to “purchase” or “carry” “margin stock” within the
respective meanings of each of the quoted terms under Regulation U of the Board
of Governors of the Federal Reserve System as now and from time to time
hereafter in effect.
(s) Offering
Restrictions.
Except
as previously disclosed in the SEC Reports or in the Exchange Act Filings,
or
stock or stock options granted to its employees or directors, neither it nor
any
of its Subsidiaries shall, prior to the full exercise by Calliope of the
Warrants, (x) enter into any equity line of credit agreement or similar
agreement with a floorless pricing feature or (y) issue, or enter into any
agreement to issue, any securities with a floorless variable/floating conversion
and/or pricing feature which are or could be (by conversion or registration)
free-trading securities (i.e. common stock subject to a registration
statement).
29
(t) Authorization
and Reservation of Shares.
The
Parent shall at all times have authorized and reserved a sufficient number
of
shares of Common Stock to provide for the full conversion of the Secured
Convertible Term Note and the full exercise of the Warrants.
(u) FIRPTA.
Neither
it, nor any of its Subsidiaries, is a “United States real property holding
corporation” as such term is defined in Section 897(c)(2) of the Code and
Treasury Regulation Section 1.897-2 promulgated thereunder and it and each
of
its Subsidiaries shall at no time take any action or otherwise acquire any
interest in any asset or property to the extent the effect of which shall cause
it and/or such Subsidiary, as the case may be, to be a “United States real
property holding corporation” as such term is defined in Section 897(c)(2) of
the Code and Treasury Regulation Section 1.897-2 promulgated
thereunder.
(v) Purchase
Orders.
(i) Upon
delivery of Products to the Golf Course Customer pursuant to a Purchase Order,
it shall issue or cause to be issued a Purchase Order Invoice (and deliver
any
other related documents required by the applicable Purchase Order for issuance
of an invoice on account of such Purchase Order) to the Approved Leasing Company
named in such Purchased Order for the full Purchase Order Price. The Purchase
Order Invoice shall direct the Approved Leasing Company to make payment to
the
Lockboxes. No Company shall accept any payment (including rebates, set-offs,
and
other adjustments) with respect to any Purchase Order Invoice other than through
the Lockboxes. Each Company shall receive and hold in trust for the sole and
exclusive benefit of Calliope all sums and instruments representing payment
of
any Purchase Order Invoice and all Purchase Order Proceeds which for any reason
come into the possession of such Company, its agents, representatives or any
other party acting on behalf of such Company, and promptly to deliver or cause
delivery of such sums to Calliope;
(ii) It
shall
(A) take all actions necessary for the packaging and the shipment of Products
to
the Golf Course Customers in accordance with the Purchase Orders, including,
without limitation, processing, packaging, shipping, warehousing, and insuring
Products in accordance with the specifications set forth in the applicable
Purchase Order and this Agreement, (B) provide Calliope with written notice
(including the date shipped, the destination, the expected delivery date and
the
shipper) of each shipment of Purchase Order Inventory immediately following
shipment thereof, (C) immediately after issuance to the Approved Leasing Company
deliver a copy of each Purchase Order Invoice to Calliope, and (D) collect
in a
manner consistent with past practices, payment with respect to each Purchase
Order Invoice.
(iii) It
shall
immediately notify Calliope in writing if (A) an Eligible Purchase Order is
cancelled by the Approved Leasing Company or the Golf Course Customer listed
thereon, (B) an Eligible Purchase Order becomes a Delinquent Purchase Order
or
(C) an Approved Leasing Company or a Golf Course Customer asserts any claim,
return, dispute or offset regarding the Products or payment
therefore.
(iv) It
shall
deliver or cause to be delivered to Calliope all documents, notices,
instruments, statements and bills of lading relating to Products and Purchase
Order Inventory relating to an Eligible Purchase Order.
30
(w) Financing
Right of First Refusal.
(i) Each
Company hereby grants to Calliope a right of first refusal to provide any
Additional Financing (as defined below) to be issued by any Company and/or
any
of its Subsidiaries (the “Additional
Financing Parties”),
subject to the following terms and conditions. From and after the date hereof,
prior to the incurrence of any additional indebtedness and/or the sale or
issuance of any equity interests of the Additional Financing Parties (an
“Additional
Financing”),
Company Agent shall notify Calliope of such Additional Financing. In connection
therewith, Company Agent shall submit a fully executed term sheet (a
“Proposed
Term Sheet”)
to
Calliope setting forth the terms, conditions and pricing of any such Additional
Financing (such financing to be negotiated on “arm’s length” terms and the terms
thereof to be negotiated in good faith) proposed to be entered into by the
Additional Financing Parties. Calliope shall have the right, but not the
obligation, to deliver to Company Agent its own proposed term sheet (the
“Calliope
Term Sheet”)
setting forth the terms and conditions upon which Calliope would be willing
to
provide such Additional Financing to the Additional Financing Parties. The
Calliope Term Sheet shall contain terms no less favorable to the Additional
Financing Parties than those outlined in Proposed Term Sheet. Calliope shall
deliver to Company Agent the Calliope Term Sheet within ten Business Days of
receipt of each such Proposed Term Sheet. If the provisions of the Calliope
Term
Sheet are at least as favorable to the Additional Financing Parties as the
provisions of the Proposed Term Sheet, the Additional Financing Parties shall
enter into and consummate the Additional Financing transaction outlined in
the
Calliope Term Sheet. Notwithstanding the foregoing, to the extent Calliope’s
right of first refusal set forth herein conflicts with any Investor First
Refusal Rights, Calliope’s right of first refusal shall be subject to such
Investor First Refusal Rights.
(ii) It
shall
not, and shall not permit its Subsidiaries to, agree, directly or indirectly,
to
any restriction with any Person which limits the ability of Calliope to
consummate an Additional Financing with it or any of its Subsidiaries other
than
the Investor First Refusal Rights.
(x) ProLink
UK.
It
shall not (i) permit ProLink UK to engage in any business of a material nature
or own any assets or (ii) transfer, sell or assign any of its assets to ProLink
UK.
(y) Financial
Covenants.
Each
Company agrees with Calliope to each of the following:
(i) Minimum
Consolidated EBITDA.
The
Parent shall not have, on the last day of each fiscal quarter commencing with
the fiscal quarter ending September 30, 2009, Consolidated EBITDA for the four
(4) fiscal quarter period ending on such day less than $5,000,000.
(ii) Maximum
Consolidated Leverage Ratio.
The
Parent shall not have, on the last day of each fiscal quarter commencing with
the fiscal quarter ending September 30, 2009, a Consolidated Leverage Ratio
greater than 4.0 to 1.0.
31
(iii) Minimum
Consolidated Fixed Charge Coverage Ratio.
The
Parent shall not have, on the last day of each fiscal quarter commencing with
the fiscal quarter ending September 30, 2009, a Consolidated Fixed Charge
Coverage Ratio for the four (4) fiscal quarter period ending on such day less
than 1.0
to
1.0.
14. Further
Assurances.
At any
time and from time to time, upon the written request of Calliope and at the
sole
expense of Companies, each Company shall promptly and duly execute and deliver
any and all such further instruments and documents and take such further action
as Calliope may reasonably request (a) to obtain the full benefits of this
Agreement and the Ancillary Agreements, (b) to protect, preserve and maintain
Calliope’s rights in the Collateral and under this Agreement or any Ancillary
Agreement, and/or (c) to enable Calliope to exercise all or any of the rights
and powers herein granted or any Ancillary Agreement.
15. Representations,
Warranties and Covenants of Calliope.
Calliope hereby represents, warrants and covenants to each Company as
follows:
(a) Requisite
Power and Authority.
Calliope has all necessary power and authority under all applicable provisions
of law to execute and deliver this Agreement and the Ancillary Agreements and
to
carry out their provisions. All corporate action on Calliope’s part required for
the lawful execution and delivery of this Agreement and the Ancillary Agreements
have been or will be effectively taken prior to the Closing Date. Upon their
execution and delivery, this Agreement and the Ancillary Agreements shall be
valid and binding obligations of Calliope, enforceable in accordance with their
terms, except (a) as limited by applicable bankruptcy, insolvency,
reorganization, moratorium or other laws of general application affecting
enforcement of creditors’ rights, and (b) as limited by general principles of
equity that restrict the availability of equitable and legal
remedies.
(b) Investment
Representations.
Calliope understands that the Securities are being offered pursuant to an
exemption from registration contained in the Securities Act based in part upon
Calliope’s representations contained in this Agreement, including, without
limitation, that Calliope is an “accredited investor” within the meaning of
Regulation D under the Securities Act. Calliope has received or has had full
access to all the information it considers necessary or appropriate to make
an
informed investment decision with respect to the Notes to be issued to it under
this Agreement and the Securities acquired by it upon the conversion of the
Secured Convertible Term Note and the exercise of the Warrants.
(c) Calliope
Bears Economic Risk.
Calliope has substantial experience in evaluating and investing in private
placement transactions of securities in companies similar to the Parent so
that
it is capable of evaluating the merits and risks of its investment in the Parent
and has the capacity to protect its own interests. Calliope must bear the
economic risk of this investment until the Securities are sold pursuant to
(i)
an effective registration statement under the Securities Act, or (ii) an
exemption from registration is available.
(d) Investment
for Own Account.
The
Securities are being issued to Calliope for its own account for investment
only,
and not as a nominee or agent and not with a view towards or for resale in
connection with their distribution.
32
(e) Calliope
Can Protect Its Interest.
Calliope represents that by reason of its, or of its management’s, business and
financial experience, Calliope has the capacity to evaluate the merits and
risks
of its investment in the Notes, and the Securities and to protect its own
interests in connection with the transactions contemplated in this Agreement,
and the Ancillary Agreements. Further, Calliope is aware of no publication
of
any advertisement in connection with the transactions contemplated in the
Agreement or the Ancillary Agreements.
(f) Accredited
Investor.
Calliope represents that it is an accredited investor within the meaning of
Regulation D under the Securities Act.
(g) Shorting.
Neither
Calliope nor any of its Affiliates or investment partners has, will, or will
cause any Person, to directly engage in “short sales” of the Parent’s Common
Stock as long as any amount under any Note shall remain
outstanding.
(h) Patriot
Act.
Calliope certifies that, to the best of Calliope’s knowledge, Calliope has not
been designated, and is not owned or controlled, by a “suspected terrorist” as
defined in Executive Order 13224. Calliope seeks to comply with all applicable
laws concerning money laundering and related activities. In furtherance of
those
efforts, Calliope hereby represents, warrants and covenants that: (i) none
of
the cash or property that Calliope will use to make the Loans has been or shall
be derived from, or related to, any activity that is deemed criminal under
United States law; and (ii) no disbursement by Calliope to any Company to the
extent within Calliope’s control, shall cause Calliope to be in violation of the
United States Bank Secrecy Act, the United States International Money Laundering
Control Act of 1986 or the United States International Money Laundering
Abatement and Anti-Terrorist Financing Act of 2001. Calliope shall promptly
notify the Company Agent if any of these representations ceases to be true
and
accurate regarding Calliope. Calliope agrees to provide the Company any
additional information regarding Calliope that the Company deems necessary
or
convenient to ensure compliance with all applicable laws concerning money
laundering and similar activities. Calliope understands and agrees that if
at
any time it is discovered that any of the foregoing representations are
incorrect, or if otherwise required by applicable law or regulation related
to
money laundering similar activities, Calliope may undertake appropriate actions
to ensure compliance with applicable law or regulation, including but not
limited to segregation and/or redemption of Calliope’s investment in the Parent.
Calliope further understands that the Parent may release information about
Calliope and, if applicable, any underlying beneficial owners, to proper
authorities if the Parent, in its sole discretion, determines that it is in
the
best interests of the Parent in light of relevant rules and regulations under
the laws set forth in subsection (ii) above.
(i) Limitation
on Acquisition of Common Stock.
Notwithstanding anything to the contrary contained in this Agreement, any
Ancillary Agreement, or any document, instrument or agreement entered into
in
connection with any other transaction entered into by and between Calliope
and
any Company (and/or Subsidiaries or Affiliates of any Company), Calliope shall
not acquire stock in the Parent (including, without limitation, pursuant to
a
contract to purchase, by exercising an option or warrant, by converting any
other security or instrument, by acquiring or exercising any other right to
acquire, shares of stock or other security convertible into shares of stock
in
the Parent, or otherwise, and such options, warrants, conversion or other rights
shall not be exercisable) to the extent such stock acquisition would cause
any
interest (including any original issue discount) payable by any Company to
Calliope not to qualify as portfolio interest, within the meaning of Section
881(c)(2) of the Internal Revenue Code of 1986, as amended (the “Code”)
by
reason of Section 881(c)(3) of the Code, taking into account the constructive
ownership rules under Section 871(h)(3)(C) of the Code (the “Stock
Acquisition Limitation”).
The
Stock Acquisition Limitation shall automatically become null and void without
any notice to any Company upon the earlier to occur of either (a) the Parent’s
delivery to Calliope of a Notice of Redemption (as defined in the Secured
Convertible Term Note) or (b) the existence of an Event of Default at a time
when the average closing price of the Common Stock as reported by Bloomberg,
L.P. on the Principal Market for the immediately preceding five trading days
is
greater than or equal to 150% of the Fixed Conversion Price (as defined in
the
Secured Convertible Term Note).
33
16. Power
of Attorney.
Each
Company hereby appoints Calliope, or any other Person whom Calliope may
designate as such Company’s attorney, with power to: (a)(i) execute any security
related documentation on such Company’s behalf and to supply any omitted
information and correct patent errors in any documents executed by such Company
or on such Company’s behalf; (ii) to file financing statements against such
Company covering the Collateral (and, in connection with the filing of any
such
financing statements, describe the Collateral as “all assets and all personal
property, whether now owned and/or hereafter acquired” (or any substantially
similar variation thereof)); (iii) sign such Company’s name on any invoice or
xxxx of lading relating to any Accounts, drafts against Account Debtors,
schedules and assignments of Accounts, notices of assignment, financing
statements and other public records, verifications of Account and notices to
or
from Account Debtors; and (iv) to do all other things Xxxxxxxx xxxxx necessary
to carry out the terms of Section 6 of this Security Agreement and (b) upon
the
occurrence and during the continuance of an Event of Default; (v) endorse such
Company’s name on any checks, notes, acceptances, money orders, drafts or other
forms of payment or security that may come into Calliope’s possession; (vi)
verify the validity, amount or any other matter relating to any Account by
mail,
telephone, telegraph or otherwise with Account Debtors; (vii) do all other
things necessary to carry out this Agreement, any Ancillary Agreement and all
related documents; and (viii) notify the post office authorities to change
the
address for delivery of such Company’s mail to an address designated by
Calliope, and to receive, open and dispose of all mail addressed to such
Company. Each Company hereby ratifies and approves all acts of the attorney.
Neither Calliope, nor the attorney will be liable for any acts or omissions
or
for any error of judgment or mistake of fact or law, except for gross negligence
or willful misconduct. This power, being coupled with an interest, is
irrevocable so long as Calliope has a security interest and until the
Obligations have been fully satisfied.
17. Term
of Agreement.
(a) Calliope’s
agreement to make Loans and extend financial accommodations under and in
accordance with the terms of this Agreement or any Ancillary Agreement shall
continue in full force and effect until the expiration of the Term applicable
to
such Loans. At Calliope’s election following the occurrence of an Event of
Default that is continuing, Calliope may terminate this Agreement. The
termination of the Agreement shall not affect any of Calliope’s rights hereunder
or under any Ancillary Agreement and the provisions hereof and thereof shall
continue to be fully operative until all the Obligations have been irrevocably
paid in full.
34
(b) If
the
Obligations in respect of the Term Loan are prepaid in full prior to the end
of
the Term Loan Term, the Companies shall jointly and severally pay to Laurus,
upon the effective date of such prepayment, the Redemption Amount (as defined
in
the Secured Convertible Term Note) and such other amounts required to be paid
by
the Companies to Calliope at such time pursuant to and in accordance with the
terms of the Secured Convertible Term Note.
18. Termination
of Lien.
The
Liens and rights granted to Calliope hereunder and any Ancillary Agreements
and
the financing statements filed in connection herewith or therewith shall
continue in full force and effect, notwithstanding the termination of this
Agreement or the fact that any Company’s account may from time to time be
temporarily in a zero or credit position, until all of the Obligations have
been
indefeasibly paid or performed in full and this Agreement has been terminated
in
accordance with the terms of this Agreement. Calliope shall not be required
to
send termination statements to any Company, or to file them with any filing
office, unless and until this Agreement and the Ancillary Agreements shall
have
been terminated in accordance with their terms and all Obligations indefeasibly
paid in full in immediately available funds.
19. Events
of Default.
The
occurrence of any of the following shall constitute an “Event
of Default”:
(a) failure
to make payment of any principal, interest, fees, costs, charges, expenses,
liquidated damages or other sums payable from time to time hereunder or under
any of the Ancillary Agreements when required hereunder or thereunder, and,
in
any such case, such failure shall continue for a period of three (3) days
following the date upon which any such payment was due;
(b) failure
by any Company or any of its Subsidiaries to pay any taxes in an amount in
excess of $10,000 (inclusive of interest, penalties, fees and fines) when due
unless such taxes are being contested in good faith by appropriate proceedings
and with respect to which adequate reserves have been provided on such Company’s
and/or such Subsidiary’s books;
(c) failure
to perform under, and/or committing any breach of, in any material respect,
this
Agreement, any Ancillary Agreement or any covenant contained herein or therein,
which failure or breach shall continue without remedy for a period of fifteen
(15) Business Days after the occurrence thereof;
(d) any
representation, warranty or statement made by any Company or any of its
Subsidiaries hereunder, in any Ancillary Agreement, any certificate, statement
or document delivered pursuant to the terms hereof, or in connection with the
transactions contemplated by this Agreement should prove to be false or
misleading in any material respect on the date as of which made or deemed
made;
(e) the
occurrence of any default (or similar term) in the observance or performance
of
any other agreement or condition relating to any indebtedness or contingent
obligation of any Company or any of its Subsidiaries in excess of $50,000 beyond
the period of grace (if any), the effect of which default is to cause, or permit
the holder or holders of such indebtedness or beneficiary or beneficiaries
of
such contingent obligation to cause, such indebtedness to become due prior
to
its stated maturity or such contingent obligation to become
payable;
35
(f) attachments
or levies in excess of $50,000 in the aggregate are made upon any Company’s
assets or a judgment is rendered against any Company’s property involving a
liability of more than $50,000 which shall not have been vacated, discharged,
stayed or bonded within thirty (30) days from the entry thereof;
(g) any
change in any Company’s or any of its Subsidiary’s condition or affairs
(financial or otherwise) which in Calliope’s reasonable, good faith opinion,
could reasonably be expected to have a Material Adverse Effect;
(h) any
Lien
created hereunder or under any Ancillary Agreement for any reason ceases to
be
or is not a valid and perfected Lien having a first priority
interest;
(i) any
Company or any of its Subsidiaries shall (i) apply for, consent to or
suffer to exist the appointment of, or the taking of possession by, a receiver,
custodian, trustee or liquidator of itself or of all or a substantial part
of
its property, (ii) make a general assignment for the benefit of creditors,
(iii) commence a voluntary case under the federal bankruptcy laws (as now or
hereafter in effect), (iv) be adjudicated a bankrupt or insolvent, (v) file
a
petition seeking to take advantage of any other law providing for the relief
of
debtors, (vi) acquiesce to without challenge within ten (10) days of the filing
thereof, or failure to have dismissed within forty-five (45) days, any petition
filed against it in any involuntary case under such bankruptcy laws, or (vii)
take any action for the purpose of effecting any of the foregoing;
(j) any
Company or any of its Subsidiaries shall admit in writing its inability, or
be
generally unable, to pay its debts as they become due or cease operations of
its
present business;
(k) any
Company or any of its Subsidiaries directly or indirectly sells, assigns,
transfers, conveys, or suffers or permits to occur any sale, assignment,
transfer or conveyance of any assets of such Company or any interest therein,
except as permitted herein;
(l) any
“Person” or “group” (as such terms are defined in Sections 13(d) and 14(d) of
the Exchange Act, as in effect on the date hereof), other than Calliope, is
or
becomes the “beneficial owner” (as defined in Rules 13(d)-3 and 13(d)-5 under
the Exchange Act), directly or indirectly, of fifty percent (50%) or more on
a
fully diluted basis of the then outstanding voting equity interest of the Parent
(other than a “Person” or “group” that beneficially owns fifty percent (50%) or
more of such outstanding voting equity interests of the Parent on the date
hereof), (ii) the Board of Directors of the Parent shall cease to consist of
a
majority of the Board of Directors of the Parent on the date hereof (or
directors appointed by a majority of the board of directors in effect
immediately prior to such appointment) or (iii) the Parent or any of its
Subsidiaries merges or consolidates with, or sells all or substantially all
of
its assets to, any other person or entity;
36
(m) the
indictment of any Company or any of its Subsidiaries or any executive officer
of
any Company or any of its Subsidiaries under any criminal statute, or
commencement of any civil proceeding or criminal proceeding against any Company
or any of its Subsidiaries or any executive officer of any Company or any of
its
Subsidiaries pursuant to which statute or proceeding penalties or remedies
sought or available include forfeiture of any of the property of any Company
or
any of its Subsidiaries, which property has a fair market value in excess of
$50,000;
(n) an
Event
of Default (or similar term) shall occur under and as defined in any Note or
in
any other Ancillary Agreement;
(o) any
Company or any of its Subsidiaries shall breach any term or provision of any
Ancillary Agreement to which it is a party (including, without limitation,
Section 7(e) of the Registration Rights Agreement), in any material respect
which breach is not cured within any applicable cure or grace period provided
in
respect thereof (if any);
(p) any
Company or any of its Subsidiaries attempts to terminate, challenges the
validity of, or its liability under this Agreement or any Ancillary Agreement,
or any proceeding shall be brought to challenge the validity, binding effect
of
any Ancillary Agreement or any Ancillary Agreement ceases to be a valid, binding
and enforceable obligation of such Company or any of its Subsidiaries (to the
extent such Persons are a party thereto);
(q) an
SEC
stop trade order or Principal Market trading suspension of the Common Stock
shall be in effect for five (5) consecutive days or five (5) days during a
period of ten (10) consecutive days, excluding in all cases a suspension of
all
trading on a Principal Market, provided that the Parent shall not have been
able
to cure such trading suspension within thirty (30) days of the notice thereof
or
list the Common Stock on another Principal Market within sixty (60) days of
such
notice; or
(r) The
Parent’s failure to deliver Common Stock to Calliope pursuant to and in the form
required by the Secured Convertible Term Note, the Warrant and this Agreement,
if such failure to deliver Common Stock shall not be cured within two (2)
Business Days or any Company is required to issue a replacement Note to Calliope
and such Company shall fail to deliver such replacement Note within seven (7)
Business Days following a request by Calliope to issue such replacement
Note.
37
20. Remedies.
Following the occurrence of an Event of Default that is continuing, Calliope
shall have the right to demand repayment in full of all Obligations, whether
or
not otherwise due. Until all Obligations have been fully and indefeasibly
satisfied, Calliope shall retain its Lien in all Collateral. Calliope shall
have, in addition to all other rights provided herein and in each Ancillary
Agreement, the rights and remedies of a secured party under the UCC, and under
other applicable law, all other legal and equitable rights to which Calliope
may
be entitled, including the right to take immediate possession of the Collateral,
to require each Company to assemble the Collateral, at Companies’ joint and
several expense, and to make it available to Calliope at a place designated
by
Calliope which is reasonably convenient to both parties and to enter any of
the
premises of any Company or wherever the Collateral shall be located, with or
without force or process of law, and to keep and store the same on said premises
until sold (and if said premises be the property of any Company, such Company
agrees not to charge Calliope for storage thereof), and the right to apply
for
the appointment of a receiver for such Company’s property. Further, Calliope
may, at any time or times after the occurrence of an Event of Default that
is
continuing, sell and deliver all Collateral held by or for Calliope at public
or
private sale for cash, upon credit or otherwise, at such prices and upon such
terms as Calliope, in Calliope’s sole discretion, deems advisable or Calliope
may otherwise recover upon the Collateral in any commercially reasonable manner
as Calliope, in its sole discretion, deems advisable. The requirement of
reasonable notice shall be met if such notice is mailed postage prepaid to
Company Agent at Company Agent’s address as shown in Calliope’s records, at
least ten (10) days before the time of the event of which notice is being given.
Calliope may be the purchaser at any sale, if it is public. In connection with
the exercise of the foregoing remedies, Calliope is granted permission to use
all of each Company’s Intellectual Property. The proceeds of sale shall be
applied first to all costs and expenses of sale, including reasonable attorneys’
fees, and second to the payment (in whatever order Calliope elects) of all
Obligations. After the indefeasible payment and satisfaction in full of all
of
the Obligations, and after the payment by Calliope of any other amount required
by any provision of law, including Section 9-608(a)(1) of the UCC (but only
after Calliope has received what Calliope considers reasonable proof of a
subordinate party’s security interest), the surplus, if any, shall be paid to
Company Agent (for the benefit of the applicable Companies) or its
representatives or to whosoever may be lawfully entitled to receive the same,
or
as a court of competent jurisdiction may direct. The Companies shall remain
jointly and severally liable to Calliope for any deficiency. The parties hereto
each hereby agree that the exercise by any party hereto of any right granted
to
it or the exercise by any party hereto of any remedy available to it (including,
without limitation, the issuance of a notice of redemption, a borrowing request
and/or a notice of default), in each case, hereunder or under any Ancillary
Agreement shall not constitute confidential information and no party shall
have
any duty to the other party to maintain such information as confidential, except
for the portions of such publicly filed documents that are subject to
confidential treatment request made by the Companies to the SEC.
21. Waivers.
To the
full extent permitted by applicable law, each Company hereby waives (a)
presentment, demand and protest, and notice of presentment, dishonor, intent
to
accelerate, acceleration, protest, default, nonpayment, maturity, release,
compromise, settlement, extension or renewal of any or all of this Agreement
and
the Ancillary Agreements or any other notes, commercial paper, Accounts,
contracts, Documents, Instruments, Chattel Paper and guaranties at any time
held
by Calliope on which such Company may in any way be liable, and hereby ratifies
and confirms whatever Calliope may do in this regard; (b) all rights to notice
and a hearing prior to Calliope’s taking possession or control of, or to
Calliope’s replevy, attachment or levy upon, any Collateral or any bond or
security that might be required by any court prior to allowing Calliope to
exercise any of its remedies; and (c) the benefit of all valuation, appraisal
and exemption laws. Each Company acknowledges that it has been advised by
counsel of its choices and decisions with respect to this Agreement, the
Ancillary Agreements and the transactions evidenced hereby and
thereby.
38
22. Expenses.
The
Companies shall jointly and severally pay all of Calliope’s out-of-pocket costs
and expenses, including reasonable fees and disbursements of outside counsel
and
appraisers, in connection with (x) subject to the limitations set forth in
Section 5(b)(iii), the preparation, execution and delivery of this Agreement
and
the Ancillary Agreements, and (y) in connection with the prosecution or defense
of any action, contest, dispute, suit or proceeding concerning any matter in
any
way arising out of, related to or connected with this Agreement or any Ancillary
Agreement. The Companies shall also jointly and severally pay all of Calliope’s
reasonable fees, charges, out-of-pocket costs and expenses, including fees
and
disbursements of counsel and appraisers, in connection with (a) the preparation,
execution and delivery of any waiver, any amendment thereto or consent proposed
or executed in connection with the transactions contemplated by this Agreement
or the Ancillary Agreements, (b) Calliope’s obtaining performance of the
Obligations under this Agreement and any Ancillary Agreements, including, but
not limited to, the enforcement or defense of Calliope’s security interests,
assignments of rights and Liens hereunder as valid perfected security interests,
(c) any attempt to inspect, verify, protect, collect, sell, liquidate or
otherwise dispose of any Collateral, (d) any appraisals or reappraisals of
any
property (real or personal) pledged to Calliope by any Company or any of its
Subsidiaries as Collateral for, or any other Person as security for, the
Obligations hereunder and (e) any consultations in connection with any of the
foregoing. The Companies shall also jointly and severally pay Calliope’s
customary bank charges for all bank services (including wire transfers)
performed or caused to be performed by Calliope for any Company or any of its
Subsidiaries at any Company’s or such Subsidiary’s request or in connection with
any Company’s loan account with Calliope. All such costs and expenses together
with all filing, recording and search fees, taxes and interest payable by the
Companies to Calliope shall be payable on demand and shall be secured by the
Collateral. If any tax by any Governmental Authority is or may be imposed on
or
as a result of any transaction between any Company and/or any Subsidiary
thereof, on the one hand, and Calliope on the other hand, which Calliope is
or
may be required to withhold or pay (including, without limitation, as a result
of a breach by any Company or any of its Subsidiaries of Section 13(u) herein),
the Companies hereby jointly and severally indemnifies and holds Calliope
harmless in respect of such taxes, and the Companies will repay to Calliope
the
amount of any such taxes which shall be charged to the Companies’ account; and
until the Companies shall furnish Calliope with indemnity therefor (or supply
Calliope with evidence satisfactory to it that due provision for the payment
thereof has been made), Calliope may hold without interest any balance standing
to each Company’s credit and Calliope shall retain its Liens in any and all
Collateral.
23. Assignment
By Calliope.
Calliope may assign any or all of the Obligations together with any or all
of
the security therefor to any Person and any such assignee shall succeed to
all
of Calliope’s rights with respect thereto; provided that Calliope shall not be
permitted to effect any such assignment to a competitor of any Company unless
an
Event of Default has occurred and is continuing and Calliope has given Company
Agent no less than fifteen (15) Business Days prior notice of such assignment.
Upon such assignment, Calliope shall be released from all responsibility for
the
Collateral to the extent same is assigned to any transferee. Calliope may from
time to time sell or otherwise grant participations in any of the Obligations
and the holder of any such participation shall, subject to the terms of any
agreement between Calliope and such holder, be entitled to the same benefits
as
Calliope with respect to any security for the Obligations in which such holder
is a participant. Each Company agrees that each such holder may exercise any
and
all rights of banker’s lien, set-off and counterclaim with respect to its
participation in the Obligations as fully as though such Company were directly
indebted to such holder in the amount of such participation.
39
24. No
Waiver; Cumulative Remedies.
Failure
by Calliope to exercise any right, remedy or option under this Agreement, any
Ancillary Agreement or any supplement hereto or thereto or any other agreement
between or among any Company and Calliope or delay by Calliope in exercising
the
same, will not operate as a waiver; no waiver by Calliope will be effective
unless it is in writing and then only to the extent specifically stated.
Calliope’s rights and remedies under this Agreement and the Ancillary Agreements
will be cumulative and not exclusive of any other right or remedy which Calliope
may have.
25. Application
of Payments.
Each
Company irrevocably waives the right to direct the application of any and all
payments at any time or times hereafter received by Calliope from or on such
Company’s behalf and each Company hereby irrevocably agrees that Calliope shall
have the continuing exclusive right to apply and reapply any and all payments
received at any time or times hereafter against the Obligations hereunder in
such manner as Calliope may deem advisable notwithstanding any entry by Calliope
upon any of Calliope’s books and records.
26. Indemnity.
Each
Company hereby jointly and severally indemnifies and holds Calliope, and its
respective affiliates, employees, attorneys and agents (each, an “Indemnified
Person”),
harmless from and against any and all suits, actions, proceedings, claims,
damages, losses, liabilities and expenses of any kind or nature whatsoever
(including reasonable attorneys’ fees and disbursements and other costs of
investigation or defense, including those incurred upon any appeal) which may
be
instituted or asserted against or incurred by any such Indemnified Person as
the
result of credit having been extended, suspended or terminated under this
Agreement or any of the Ancillary Agreements or with respect to the execution,
delivery, enforcement, performance and administration of, or in any other way
arising out of or relating to, this Agreement, the Ancillary Agreements or
any
other documents or transactions contemplated by or referred to herein or therein
and any actions or failures to act with respect to any of the foregoing, except
to the extent that any such indemnified liability is finally determined by
a
court of competent jurisdiction to have resulted solely from such Indemnified
Person’s gross negligence or willful misconduct. NO INDEMNIFIED PERSON SHALL BE
RESPONSIBLE OR LIABLE TO ANY COMPANY OR TO ANY OTHER PARTY OR TO ANY SUCCESSOR,
ASSIGNEE OR THIRD PARTY BENEFICIARY OR ANY OTHER PERSON ASSERTING CLAIMS
DERIVATIVELY THROUGH SUCH PARTY, FOR INDIRECT, PUNITIVE, EXEMPLARY OR
CONSEQUENTIAL DAMAGES WHICH MAY BE ALLEGED AS A RESULT OF CREDIT HAVING BEEN
EXTENDED, SUSPENDED OR TERMINATED UNDER THIS AGREEMENT OR ANY ANCILLARY
AGREEMENT OR AS A RESULT OF ANY OTHER TRANSACTION CONTEMPLATED HEREUNDER OR
THEREUNDER.
27. Revival.
The
Companies further agree that to the extent any Company makes a payment or
payments to Calliope, which payment or payments or any part thereof are
subsequently invalidated, declared to be fraudulent or preferential, set aside
and/or required to be repaid to a trustee, receiver or any other party under
any
bankruptcy act, state or federal law, common law or equitable cause, then,
to
the extent of such payment or repayment, the obligation or part thereof intended
to be satisfied shall be revived and continued in full force and effect as
if
said payment had not been made.
40
28. Borrowing
Agency Provisions.
(a) Each
Company hereby irrevocably designates Company Agent to be its attorney and
agent
and in such capacity to borrow, sign and endorse notes, and execute and deliver
all instruments, documents, writings and further assurances now or hereafter
required hereunder, on behalf of such Company, and hereby authorizes Calliope
to
pay over or credit all loan proceeds hereunder in accordance with the request
of
Company Agent.
(b) The
handling of this credit facility as a co-borrowing facility with a borrowing
agent in the manner set forth in this Agreement is solely as an accommodation
to
the Companies and at their request. Calliope shall not incur any liability
to
any Company as a result thereof. To induce Calliope to do so and in
consideration thereof, each Company hereby indemnifies Calliope and holds
Calliope harmless from and against any and all liabilities, expenses, losses,
damages and claims of damage or injury asserted against Calliope by any Person
arising from or incurred by reason of the handling of the financing arrangements
of the Companies due to the nature of this credit facility being a co-borrowing
facility with a borrowing agent, reliance by Calliope on any request or
instruction from Company Agent or any other action taken by Calliope with
respect to this Paragraph 28, except to the extent that such liabilities,
expenses, losses, damages and claims of damage or injury are solely the result
of gross negligence or willful misconduct by Calliope.
(c) All
Obligations shall be joint and several, and the Companies shall make payment
upon the maturity of the Obligations by acceleration or otherwise, and such
obligation and liability on the part of the Companies shall in no way be
affected by any extensions, renewals and forbearance granted by Calliope to
any
Company, failure of Calliope to give any Company notice of borrowing or any
other notice, any failure of Calliope to pursue to preserve its rights against
any Company, the release by Calliope of any Collateral now or thereafter
acquired from any Company, and such agreement by any Company to pay upon any
notice issued pursuant thereto is unconditional and unaffected by prior recourse
by Calliope to any Company or any Collateral for such Company’s Obligations or
the lack thereof.
(d) Each
Company expressly waives any and all rights of subrogation, reimbursement,
indemnity, exoneration, contribution or any other claim which such Company
may
now or hereafter have against the other or other Person directly or contingently
liable for the Obligations, or against or with respect to any other’s property
(including, without limitation, any property which is Collateral for the
Obligations), arising from the existence or performance of this Agreement,
until
all Obligations have been indefeasibly paid in full and this Agreement has
been
irrevocably terminated.
(e) Each
Company represents and warrants to Calliope that (i) Companies have one or
more
common shareholders, directors and officers, (ii) the businesses and corporate
activities of Companies are closely related to, and substantially benefit,
the
business and corporate activities of Companies, (iii) the financial and other
operations of Companies are performed on a combined basis as if Companies
constituted a consolidated corporate group, (iv) Companies will receive a
substantial economic benefit from entering into this Agreement and will receive
a substantial economic benefit from the application of each Loan hereunder,
in
each case, whether or not such amount is used directly by any Company and (v)
all requests for Loans hereunder by the Company Agent are for the exclusive
and
indivisible benefit of the Companies as though, for purposes of this Agreement,
the Companies constituted a single entity.
41
29. Notices.
Any
notice or request hereunder may be given to any Company, Company Agent or
Calliope at the respective addresses set forth below or as may hereafter be
specified in a notice designated as a change of address under this Section.
Any
notice or request hereunder shall be given by registered or certified mail,
return receipt requested, hand delivery, overnight mail or facsimile (confirmed
by mail). Notices and requests shall be, in the case of those by hand delivery,
deemed to have been given when delivered to any officer of the party to whom
it
is addressed, in the case of those by mail or overnight mail, deemed to have
been given three (3) Business Days after the date when deposited in the mail
or
with the overnight mail carrier, and, in the case of a facsimile, when
confirmed.
Notices
shall be provided as follows:
If
to Calliope:
|
|
Calliope
Capital Corporation
000
Xxxxxx Xxxx, Xxxxx X
Xxxxx,
Xxxxxxxx 00000
Facsimile:
(000) 000-0000
|
With
a copy to:
|
Calliope
Capital Corporation
c/o
Laurus Capital Management, LLC
000
Xxxxxxx Xxxxxx,00xx Xxxxx
Xxx
Xxxx, Xxx Xxxx 00000
Attention:
Portfolio Services
Telephone:
(000) 000-0000
Facsimile:
(000) 000-0000
|
|
and:
|
Loeb
and Xxxx, XXX
000
Xxxx Xxxxxx
Xxx
Xxxx, Xxx Xxxx
Attention:
Xxxxx Xxxxxxxx, Esq.
Telephone:
(000) 000-0000
Facsimile:
(000) 000-0000
|
|
If
to any Company,
or
Company Agent:
|
000
X. Xxxxxx Xxxx
Xxxxxxxx,
Xxxxxxx 00000
Attention:
Xxxxx Xxxxx, General Counsel
Telephone:
(000) 000-0000
Facsimile:
(000) 000-0000
|
42
With
a copy to:
|
Mintz
Xxxxx Xxxx Xxxxxx Xxxxxxx and Xxxxx P.C.
Chrysler
Center
000
Xxxxx Xxxxxx
Xxx
Xxxx, Xxx Xxxx 00000
Attention:
Xxxx Xxxxxxxxxx, Esq.
Telephone:
(000) 000-0000
Facsimile:
(000) 000-0000
|
or
such
other address as may be designated in writing hereafter in accordance with
this
Section 29 by such Person.
30. Governing
Law, Jurisdiction and Waiver of Jury Trial.
(a) THIS
AGREEMENT AND THE ANCILLARY AGREEMENTS SHALL BE GOVERNED BY AND CONSTRUED AND
ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO
CONTRACTS MADE AND PERFORMED IN SUCH STATE, WITHOUT REGARD TO PRINCIPLES OF
CONFLICTS OF LAW.
(b) EACH
COMPANY HEREBY CONSENTS AND AGREES THAT THE STATE OR FEDERAL COURTS LOCATED
IN
THE COUNTY OF NEW YORK, STATE OF NEW YORK SHALL HAVE EXCLUSIVE JURISDICTION
TO
HEAR AND DETERMINE ANY CLAIMS OR DISPUTES BETWEEN ANY COMPANY, ON THE ONE HAND,
AND CALLIOPE, ON THE OTHER HAND, PERTAINING TO THIS AGREEMENT OR ANY OF THE
ANCILLARY AGREEMENTS OR TO ANY MATTER ARISING OUT OF OR RELATED TO THIS
AGREEMENT OR ANY OF THE ANCILLARY AGREEMENTS; PROVIDED,
THAT
CALLIOPE AND EACH COMPANY ACKNOWLEDGE THAT ANY APPEALS FROM THOSE COURTS MAY
HAVE TO BE HEARD BY A COURT LOCATED OUTSIDE OF THE COUNTY OF NEW YORK, STATE
OF
NEW YORK; AND FURTHER PROVIDED,
THAT
NOTHING IN THIS AGREEMENT SHALL BE DEEMED OR OPERATE TO PRECLUDE CALLIOPE FROM
BRINGING SUIT OR TAKING OTHER LEGAL ACTION IN ANY OTHER JURISDICTION TO COLLECT
THE OBLIGATIONS, TO REALIZE ON THE COLLATERAL OR ANY OTHER SECURITY FOR THE
OBLIGATIONS, OR TO ENFORCE A JUDGMENT OR OTHER COURT ORDER IN FAVOR OF CALLIOPE.
EACH COMPANY EXPRESSLY SUBMITS AND CONSENTS IN ADVANCE TO SUCH JURISDICTION
IN
ANY ACTION OR SUIT COMMENCED IN ANY SUCH COURT, AND EACH COMPANY HEREBY WAIVES
ANY OBJECTION THAT IT MAY HAVE BASED UPON LACK OF PERSONAL JURISDICTION,
IMPROPER VENUE OR FORUM
NON CONVENIENS.
EACH
COMPANY AND CALLIOPE HEREBY WAIVES PERSONAL SERVICE OF THE SUMMONS, COMPLAINT
AND OTHER PROCESS ISSUED IN ANY SUCH ACTION OR SUIT AND AGREES THAT SERVICE
OF
SUCH SUMMONS, COMPLAINT AND OTHER PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED
MAIL ADDRESSED TO COMPANY AGENT OR CALLIOPE, AS APPLICABLE, AT THE ADDRESS
SET
FORTH IN SECTION 29 AND THAT SERVICE SO MADE SHALL BE DEEMED COMPLETED UPON
THE
EARLIER OF COMPANY AGENT’S OR CALLIOPE’S, AS APPLICABLE, ACTUAL RECEIPT THEREOF
OR THREE (3) DAYS AFTER DEPOSIT IN THE U.S. MAILS, PROPER POSTAGE
PREPAID.
43
(c) THE
PARTIES DESIRE THAT THEIR DISPUTES BE RESOLVED BY A JUDGE APPLYING SUCH
APPLICABLE LAWS. THEREFORE, TO ACHIEVE THE BEST COMBINATION OF THE BENEFITS
OF
THE JUDICIAL SYSTEM AND OF ARBITRATION, THE PARTIES HERETO WAIVE ALL RIGHTS
TO
TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING BROUGHT TO RESOLVE ANY DISPUTE,
WHETHER ARISING IN CONTRACT, TORT, OR OTHERWISE BETWEEN CALLIOPE, AND/OR ANY
COMPANY ARISING OUT OF, CONNECTED WITH, RELATED OR INCIDENTAL TO THE
RELATIONSHIP ESTABLISHED BETWEEN THEM IN CONNECTION WITH THIS AGREEMENT, ANY
ANCILLARY AGREEMENT OR THE TRANSACTIONS RELATED HERETO OR THERETO.
31. Limitation
of Liability.
Each
Company acknowledges and understands that in order to assure repayment of the
Obligations hereunder Calliope may be required to exercise any and all of
Calliope’s rights and remedies hereunder and agrees that, except as limited by
applicable law, neither Calliope nor any of Calliope’s agents shall be liable
for acts taken or omissions made in connection herewith or therewith except
to
the extent such acts or omissions result from or constitute actual bad faith,
gross negligence or willful misconduct of Calliope or any of Calliope’s
agent.
32. Entire
Understanding; Maximum Interest.
This
Agreement and the Ancillary Agreements contain the entire understanding among
each Company and Calliope as to the subject matter hereof and thereof and any
promises, representations, warranties or guarantees not herein contained shall
have no force and effect unless in writing, signed by each Company’s and
Calliope’s respective officers. Neither this Agreement, the Ancillary
Agreements, nor any portion or provisions thereof may be changed, modified,
amended, waived, supplemented, discharged, cancelled or terminated orally or
by
any course of dealing, or in any manner other than by an agreement in writing,
signed by the party to be charged. Nothing contained in this Agreement, any
Ancillary Agreement or in any document referred to herein or delivered in
connection herewith shall be deemed to establish or require the payment of
a
rate of interest or other charges in excess of the maximum rate permitted by
applicable law. In the event that the rate of interest or dividends required
to
be paid or other charges hereunder exceed the maximum rate permitted by such
law, any payments in excess of such maximum shall be credited against amounts
owed by the Companies to Calliope and thus refunded to the
Companies.
33. Severability.
Wherever possible each provision of this Agreement or the Ancillary Agreements
shall be interpreted in such manner as to be effective and valid under
applicable law, but if any provision of this Agreement or the Ancillary
Agreements shall be prohibited by or invalid under applicable law such provision
shall be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of such provision or the remaining provisions
thereof.
44
34. Survival.
The
representations, warranties, covenants and agreements made herein shall survive
any investigation made by Calliope and the closing of the transactions
contemplated hereby; provided, however, the representations and warranties
that
relate solely to a specific date by their express terms shall only be deemed
to
have been made as of such date and are hereby represented and warranted to
have
been true and correct when made. All statements as to factual matters contained
in any certificate or other instrument delivered by or on behalf of the
Companies pursuant hereto in connection with the transactions contemplated
hereby shall be deemed to be representations and warranties by the Companies
hereunder solely as of the date of such certificate or instrument. All
indemnities set forth herein shall survive the execution, delivery and
termination of this Agreement and the Ancillary Agreements and the making and
repaying of the Obligations.
35. Captions.
All
captions are and shall be without substantive meaning or content of any kind
whatsoever.
36. Counterparts;
Facsimile Signatures.
This
Agreement may be executed in one or more counterparts, each of which shall
constitute an original and all of which taken together shall constitute one
and
the same agreement. Any signature delivered by a party via facsimile
transmission shall be deemed to be any original signature hereto.
37. Construction.
The
parties acknowledge that each party and its counsel have reviewed this Agreement
and that the normal rule of construction to the effect that any ambiguities
are
to be resolved against the drafting party shall not be employed in the
interpretation of this Agreement or any amendments, schedules or exhibits
thereto.
38. Publicity.
Each
Company hereby authorizes Calliope to make appropriate announcements of the
financial arrangement entered into by and among each Company and Calliope,
including, without limitation, announcements which are commonly known as
tombstones, in such publications and to such selected parties as Calliope shall
in its sole and absolute discretion deem appropriate, or as required by
applicable law.
39. Joinder.
It is
understood and agreed that any Person that desires to become a Company
hereunder, or is required to execute a counterpart of this Agreement after
the
date hereof pursuant to the requirements of this Agreement or any Ancillary
Agreement, shall become a Company hereunder by (a) executing a Joinder Agreement
in form and substance satisfactory to Calliope, (b) delivering supplements
to
such exhibits and annexes to this Agreement and the Ancillary Agreements as
Calliope shall reasonably request and (c) taking all actions as specified in
this Agreement as would have been taken by such Company had it been an original
party to this Agreement, in each case with all documents required above to
be
delivered to Calliope and with all documents and actions required above to
be
taken to the reasonable satisfaction of Calliope.
40. Legends.
The
Securities shall bear legends as follows;
(a) The
Secured Convertible Term Note shall bear substantially the following
legend:
“THIS
NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION OF THIS NOTE HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE,
STATE SECURITIES LAWS. THIS NOTE AND THE COMMON STOCK ISSUABLE UPON CONVERSION
OF THIS NOTE MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE OR SUCH SHARES
UNDER SAID ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO PROLINK HOLDINGS CORP. THAT SUCH REGISTRATION IS
NOT
REQUIRED.”
45
(b) Any
shares of Common Stock issued pursuant to conversion of the Secured Convertible
Term Note or exercise of the Warrants, shall bear a legend which shall be in
substantially the following form until such shares are covered by an effective
registration statement filed with the SEC:
“THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE, STATE SECURITIES LAWS.
THESE SHARES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN
THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH SECURITIES ACT AND
APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL REASONABLY
SATISFACTORY TO PROLINK HOLDINGS CORP. THAT SUCH REGISTRATION IS NOT
REQUIRED.”
(c) The
Warrants shall bear substantially the following legend:
“THIS
WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE
STATE SECURITIES LAWS. THIS WARRANT AND THE COMMON SHARES ISSUABLE UPON EXERCISE
OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED
IN
THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT OR THE
UNDERLYING SHARES OF COMMON STOCK UNDER SAID ACT AND APPLICABLE STATE SECURITIES
LAWS OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO PROLINK HOLDINGS CORP.
THAT SUCH REGISTRATION IS NOT REQUIRED.”
[Balance
of page intentionally left blank; signature page follows.]
46
IN
WITNESS WHEREOF, the parties have executed this Security Agreement as of the
date first written above.
By:
|
|||
Name:
|
|||
Title:
|
|||
PROLINK
SOLUTIONS, LLC
|
|||
By:
|
|||
Name:
|
|||
Title:
|
CALLIOPE
CAPITAL CORPORATION
|
|||
By:
|
Laurus
Capital Management, LLC, as
|
||
investment
manager
|
|||
By:
|
|||
Name:
|
|||
Title:
|
Annex
A - Definitions
“Account
Debtor”
means
any Person who is or may be obligated with respect to, or on account of, an
Account.
“Accountants”
has
the
meaning given to such term in Section 11(a).
“Accounts”
means
all “accounts”, as such term is defined in the UCC, now owned or hereafter
acquired by any Person, including: (a) all accounts receivable, other
receivables, book debts and other forms of obligations (other than forms of
obligations evidenced by Chattel Paper or Instruments) (including any such
obligations that may be characterized as an account or contract right under
the
UCC); (b) all of such Person’s rights in, to and under all purchase orders or
receipts for goods or services; (c) all of such Person’s rights to any goods
represented by any of the foregoing (including unpaid sellers’ rights of
rescission, replevin, reclamation and stoppage in transit and rights to
returned, reclaimed or repossessed goods); (d) all rights to payment due to
such
Person for Goods or other property sold, leased, licensed, assigned or otherwise
disposed of, for a policy of insurance issued or to be issued, for a secondary
obligation incurred or to be incurred, for energy provided or to be provided,
for the use or hire of a vessel under a charter or other contract, arising
out
of the use of a credit card or charge card, or for services rendered or to
be
rendered by such Person or in connection with any other transaction (whether
or
not yet earned by performance on the part of such Person); and (e) all
collateral security of any kind given by any Account Debtor or any other Person
with respect to any of the foregoing.
“Accounts
Availability”
means
the sum of (a) ninety percent (90%) of the net face amount of Eligible Accounts
plus (b) ninety percent (90%) of the net face amount of Eligible Credit Insured
Accounts.
“Affiliate”
means,
with respect to any Person, (a) any other Person (other than a Subsidiary)
which, directly or indirectly, is in control of, is controlled by, or is under
common control with such Person, (b) any other Person that, directly or
indirectly, owns or controls, whether beneficially, or as trustee, guardian
or
other fiduciary, 25% or more of the Stock having ordinary voting power in the
election of directors of such Person, (c) any other Person who is a director,
officer, joint venturer or partner (i) of such Person, (ii) of any Subsidiary
of
such Person or (iii) of any Person described in clause (a) above or (d) in
the
case of the Companies, the immediate family members, spouses and lineal
descendants of individuals who are Affiliates of such Companies. For the
purposes of this definition, control of a Person shall mean the power (direct
or
indirect) to direct or cause the direction of the management and policies of
such Person whether by contract or otherwise; provided however, that the term
“Affiliate” shall specifically exclude Calliope.
“Ancillary
Agreements”
means
the Notes, the Warrants, the Registration Rights Agreements, each Security
Document and all other agreements, instruments, documents, mortgages, pledges,
powers of attorney, consents, assignments, contracts, notices, security
agreements, trust agreements and guarantees whether heretofore, concurrently,
or
hereafter executed by or on behalf of any Company, any of its Subsidiaries
or
any other Person or delivered to Calliope, relating to this Agreement or to
the
transactions contemplated by this Agreement or otherwise relating to the
relationship between or among any Company and Calliope as contemplated by this
Agreement, as each of the same may be amended, supplemented, restated or
otherwise modified from time to time.
“Approved
Lease”
means
a
valid and binding lease agreement, in form and substance satisfactory to
Calliope, between a Golf Course Customer and an Approved Leasing Company
pursuant to which such Golf Course Customer has agreed to lease the Products
listed thereon from such Approved Leasing Company, the effectiveness of which
is
subject only to the earlier to occur of (a) the receipt by such Approved Leasing
Company of written acknowledgement by such Golf Course Customer of the delivery
and acceptance of the Products listed on the lease agreement or (b) the passage
of ten (10) days from the date of delivery of such Products to such Golf Course
Customer during which period such Golf Course Customer has not delivered notice
to the Approved Leasing Company that it is not accepting the
Products.
“Approved
Leasing Company”
means
the leasing companies listed on Schedule 3 attached hereto and any other leasing
company approved by Calliope from time to time in its sole
discretion.
“Balance
Sheet Date”
has
the
meaning given such term in Section 12(f)(ii).
“Books
and Records”
means
all books, records, board minutes, contracts, licenses, insurance policies,
environmental audits, business plans, files, computer files, computer discs
and
other data and software storage and media devices, accounting books and records,
financial statements (actual and pro forma), filings with Governmental
Authorities and any and all records and instruments relating to the Collateral
or otherwise necessary or helpful in the collection thereof or the realization
thereupon.
“Business
Day”
means
a
day on which Calliope is open for business and that is not a Saturday, a Sunday
or other day on which banks are required or permitted to be closed in the State
of New York.
“Capital
Availability Amount”
means
$5,000,000.
“Capital
Expenditures”
means,
for any Person
for any
period, the aggregate of all expenditures, whether or not made through the
incurrence of Indebtedness, by such Person and its Subsidiaries during such
period for the acquisition, leasing (pursuant to a Capital Lease), construction,
replacement, repair, substitution or improvement of fixed or capital assets
or
additions to equipment, in each case required to be capitalized under GAAP
on a
Consolidated balance sheet of such Person.
“Capital
Lease”
means,
with respect to any Person, any lease of, or other arrangement conveying the
right to use, any property (whether real, personal or mixed) by such Person
as
lessee that has been or should be accounted for as a capital lease on a balance
sheet of such Person prepared in accordance with GAAP.
2
“Capitalized
Lease Obligations”
means,
at any time, with respect to any Capital Lease, any lease entered into as part
of any sale/leaseback transaction of any Person or any synthetic lease, the
amount of all obligations of such Person that is (or that would be, if such
synthetic lease or other lease were accounted for as a Capital Lease)
capitalized on a balance sheet of such Person prepared in accordance with
GAAP.
“Charter”
has
the
meaning given such term in Section 12(c)(iv).
“Chattel
Paper”
means
all “chattel paper,” as such term is defined in the UCC, including electronic
chattel paper, now owned or hereafter acquired by any Person.
“Closing
Date”
means
the date on which any Company shall first receive proceeds of the initial Loans
or the date hereof, if no Loan is made under the facility on the date
hereof.
“Code”
has
the
meaning given such term in Section 15(i).
“Collateral”
means
all of each Company’s property and assets, whether real or personal, tangible or
intangible, and whether now owned or hereafter acquired, or in which it now
has
or at any time in the future may acquire any right, title or interests including
all of the following property in which it now has or at any time in the future
may acquire any right, title or interest:
(a) all
Inventory;
(b) all
Equipment;
(c) all
Fixtures;
(d) all
Goods;
(e) all
General Intangibles;
(f) all
Accounts;
(g) all
Deposit Accounts, other bank accounts and all funds on deposit
therein;
(h) all
Investment Property;
(i) all
Stock;
(j) all
Chattel Paper;
(k) all
Letter-of-Credit Rights;
(l) all
Instruments;
(m) all
commercial tort claims set forth on Schedule
1(A);
(n) all
Books
and Records;
3
(o) all
Intellectual Property;
(p) all
Supporting Obligations including letters of credit and guarantees issued in
support of Accounts, Chattel Paper, General Intangibles and Investment
Property;
(q) (i)
all
money, cash and cash equivalents and (ii) all cash held as cash collateral
to
the extent not otherwise constituting Collateral, all other cash or property
at
any time on deposit with or held by Calliope for the account of any Company
(whether for safekeeping, custody, pledge, transmission or otherwise);
and
(r) all
products and Proceeds of all or any of the foregoing, tort claims and all claims
and other rights to payment including (i) insurance claims against third parties
for loss of, damage to, or destruction of, the foregoing Collateral and (ii)
payments due or to become due under leases, rentals and hires of any or all
of
the foregoing and Proceeds payable under, or unearned premiums with respect
to
policies of insurance in whatever form.
“Common
Stock”
means
the shares of stock representing the Parent’s common equity
interests.
“Company
Agent”
means
the Parent.
“Compliance
Certificate”
means
a
certificate substantially in the form of Exhibit C.
“Consolidated”
means,
with respect to any Person, the accounts of such Person and its Subsidiaries
consolidated in accordance with GAAP.
“Consolidated
Cash Interest Expense”
means,
with respect to any Person for any period, the Consolidated Interest Expense
of
such Person for such period less
the sum
of, in each case to the extent included in the definition of Consolidated
Interest Expense, (a) the amortized amount of debt discount and debt issuance
costs, (b) charges relating to write-ups or write-downs in the book or carrying
value of existing Consolidated Total Debt, (c) interest payable in evidences
of
Indebtedness or by addition to the principal of the related Indebtedness and
(d)
other non-cash interest.
“Consolidated
EBITDA”
means,
with respect to any Person for any period, (a) the Consolidated Net Income
of
such Person for such period plus
(b) the
sum of, in each case to the extent included in the calculation of such
Consolidated Net Income but without duplication, (i) any provision for
United States federal income taxes or other taxes measured by net income, (ii)
Consolidated Interest Expense, amortization of debt discount and commissions
and
other fees and charges associated with Indebtedness (except amortization and
expenses related to the consummation of the initial Loans on the Closing Date
and the payment of all fees, costs and expenses associated with the foregoing),
(iii) any loss from extraordinary items, (iv) any depreciation, depletion and
amortization expense, (v) any aggregate net loss on the sale of property (other
than accounts (as defined under the applicable UCC) and Inventory) outside
the
ordinary course of business and (vi) any other non-cash expenditure, charge
or loss for such period (other than any non-cash expenditure, charge or loss
relating to write-offs, write-downs or reserves with respect to accounts (as
defined under the applicable UCC) and Inventory), including the amount of any
compensation deduction as the result of any grant of Equity Interests to
employees, officers, directors or consultants and minus
(c) the
sum of, in each case to the extent included in the calculation of such
Consolidated Net Income and without duplication, (i) any credit for United
States federal income taxes or other taxes measured by net income, (ii) any
interest income, (iii) any gain from extraordinary items and any other
non-recurring gain, (iv) any aggregate net gain from the sale of property (other
than accounts (as defined in the applicable UCC) and Inventory) out of the
ordinary course of business by such Person, (v) any other non-cash gain,
including any reversal of a charge referred to in clause (b)(vi) above by reason
of a decrease in the value of any Equity Interests, and (vi) any other cash
payment in respect of expenditures, charges and losses that have been added
to
Consolidated EBITDA of such Person pursuant to clause (b)(vi) above in any
prior
period.
4
“Consolidated
Fixed Charge Coverage Ratio”
means,
with respect to any Person for any period, the ratio of (a) Consolidated EBITDA
of such Person for such period minus
Capital
Expenditures of such Person for such period minus
the
total liability for United States federal income taxes and other taxes measured
by net income actually payable by such Person in respect of such period to
(b)
the Consolidated Fixed Charges of such Person for such period.
“Consolidated
Fixed Charges”
means,
with respect to any Person for any period, the sum, determined on a Consolidated
basis, of (a) the Consolidated Cash Interest Expense of such Person and its
Subsidiaries for such period, (b) the principal amount of Consolidated Total
Debt of such Person and its Subsidiaries having a scheduled due date during
such
period, (c) all cash dividends payable by such Person and its Subsidiaries
on
Equity Interests in respect of such period to Persons other than such Person
and
its Subsidiaries and (d) all commitment fees and other costs, fees and expenses
payable by such Person and its Subsidiaries during such period in order to
effect, or because of, the incurrence of any Indebtedness.
“Consolidated
Interest Expense”
means,
for any Person for any period, (a) Consolidated total interest expense of such
Person and its Subsidiaries for such period and including, in any event, (i)
interest capitalized during such period and net costs under Interest Rate
Contracts for such period and (ii) all fees, charges, commissions, discounts
and
other similar obligations (other than reimbursement obligations) with respect
to
letters of credit, bank guarantees, banker’s acceptances, surety bonds and
performance bonds (whether or not matured) payable by such Person and its
Subsidiaries during such period minus
(b) the
sum of (i) Consolidated net gains of such Person and its Subsidiaries under
Interest Rate Contracts for such period and (ii) Consolidated interest
income of such Person and its Subsidiaries for such period.
“Consolidated
Leverage Ratio”
means,
with respect to any Person as of any date, the ratio of (a) Consolidated Total
Debt of such Person outstanding as of such date to (b) Consolidated EBITDA
for
such Person for the last period of four consecutive fiscal quarters ending
on or
before such date.
“Consolidated
Net Income”
means,
with respect to any Person, for any period, the Consolidated net income (or
loss) of such Person and its Subsidiaries for such period; provided,
however,
that
the following shall be excluded: (a) the net income of any other Person in
which
such Person or one of its Subsidiaries has a joint interest with a third-party
(which interest does not cause the net income of such other Person to be
Consolidated into the net income of such Person), except to the extent of the
amount of dividends or distributions paid to such Person or Subsidiary, (b)
the
net income of any Subsidiary of such Person that is, on the last day of such
period, subject to any restriction or limitation on the payment of dividends
or
the making of other distributions, to the extent of such restriction or
limitation and (c) the net income of any other Person arising prior to such
other Person becoming a Subsidiary of such Person or merging or consolidating
into such Person or its Subsidiaries.
5
“Consolidated
Total Debt”
of
any
Person means all Indebtedness of a type described in clause (a), (b), (c)(i),
(d), (f), (g) or (i) of the definition thereof, in each case of such Person
and
its Subsidiaries on a Consolidated basis.
“Contract
Rate”
has
the
meaning given such term in the respective Note.
“Contractual
Obligation”
means,
with respect to any Person, any provision of any indenture, mortgage, deed
of
trust, contract, undertaking, agreement or other instrument to which such Person
is a party or by which it or any of its property is bound or to which any of
its
property is subject.
“Default”
means
any act or event that, with the giving of notice or passage of time or both,
would constitute an Event of Default.
“Deposit
Accounts”
means
all “deposit accounts” as such term is defined in the UCC, now or hereafter held
in the name of any Person, including, without limitation, the
Lockboxes.
“Disclosure
Controls”
has
the
meaning given such term in Section 12(f)(iv).
“Documents”
means
all “documents”, as such term is defined in the UCC, now owned or hereafter
acquired by any Person, wherever located, including all bills of lading, dock
warrants, dock receipts, warehouse receipts, and other documents of title,
whether negotiable or non-negotiable.
6
“Eligible
Accounts”
means
each Account of each Company which conforms to the following criteria: (a)
shipment of the merchandise or the rendition of services has been completed;
(b)
no return, rejection or repossession of the merchandise has occurred;
(c) merchandise or services shall not have been rejected or disputed by the
Account Debtor and there shall not have been asserted any offset, defense or
counterclaim; (d) continues to be in full conformity with the representations
and warranties made by such Company to Calliope with respect thereto; (e)
Calliope is, and continues to be, satisfied, in its reasonable credit judgment,
with the credit standing of the Account Debtor in relation to the amount of
credit extended; (f) there are no facts existing or threatened which are likely
to result in any adverse change in an Account Debtor’s financial condition; (g)
is documented by an invoice in a form approved by Calliope and shall not be
unpaid more than ninety (90) days from invoice date; (h) not more than
twenty-five percent (25%) of the unpaid amount of invoices due from such Account
Debtor remains unpaid more than ninety (90) days from invoice date; (i) is
not
evidenced by chattel paper or an instrument of any kind with respect to or
in
payment of the Account unless such instrument is duly endorsed to and in
possession of Calliope or represents a check in payment of an Account; (j)
the
Account Debtor is located in the United States, the United Kingdom or Canada;
(k) Calliope has a first priority perfected Lien in such Account and such
Account is not subject to any Lien other than Permitted Liens; (l) does not
arise out of transactions with any employee, officer, director, stockholder
or
Affiliate of any Company; (m) is payable to such Company; (n) does not arise
out
of a xxxx and hold sale prior to shipment and does not arise out of a sale
to
any Person to which such Company is indebted; (o) is net of any returns,
discounts, claims, credits and allowances (p) is net of any royalty fees payable
by such Company in connection with such Account; (q) if the Account arises
out
of contracts between such Company, on the one hand, and the United States,
on
the other hand, any state, or any department, agency or instrumentality of
any
of them, such Company has so notified Calliope, in writing, prior to the
creation of such Account, and there has been compliance with any governmental
notice or approval requirements, including compliance with the Federal
Assignment of Claims Act; (r) is a good and valid account representing an
undisputed bona fide indebtedness incurred by the Account Debtor therein named,
for a fixed sum as set forth in the invoice relating thereto with respect to
an
unconditional sale and delivery upon the stated terms of goods sold by such
Company or work, labor and/or services rendered by such Company; (s) does not
arise out of progress xxxxxxxx prior to completion of the order; (t) the total
unpaid Accounts from such Account Debtor does not exceed twenty-five percent
(25%) of all Eligible Accounts; (u) such Company’s right to payment is absolute
and not contingent upon the fulfillment of any condition whatsoever; (v) such
Company is able to bring suit and enforce its remedies against the Account
Debtor through judicial process; (w) does not represent interest payments,
late
or finance charges owing to such Company, and (x) is otherwise satisfactory
to
Calliope as determined by Calliope in the exercise of its commercially
reasonable discretion exercised in good faith. In the event any Company requests
that Calliope include within Eligible Accounts certain Accounts of one or more
of such Company’s acquisition targets, Calliope shall at the time of such
request consider such inclusion, but any such inclusion shall be at the sole
option of Calliope and shall at all times be subject to the execution and
delivery to Calliope of all such documentation (including, without limitation,
guaranty and security documentation) as Calliope may require in its sole
discretion.
“Eligible
Credit Insured Accounts”
means
each Account of each Company which conforms to the following criteria: (a)
the
Account Debtor is not located in the United States, the United Kingdom or
Canada, (b) such Account is insured a minimum of ninety-five (95%) under an
Ex-Im Bank Multi-Buyer Export Credit Insurance Policy issued by the
Export-Import Bank of the United States, with such coverages, terms and amounts
acceptable to Calliope in its sole and absolute discretion, which credit
insurance policy has been assigned to Calliope on terms and conditions
acceptable to Calliope in its sole and absolute discretion and (c) except
for the failure to comply with subsection (j) of such definition, is otherwise
deemed an “Eligible Account” hereunder.
7
“Eligible
Purchase Order”
means
each Purchase Order of each Company which conforms to the following criteria:
(a) such Company has irrevocably directed the Approved Leasing Company to make
payments of all amounts due under such Purchase Order to the Lockboxes, (b)
copies of such Purchase Order and an Approved Lease covering the Products listed
in such Purchase Order shall be in form and substance satisfactory to Calliope,
(c) the Products set forth in such Purchase Order have been shipped to the
applicable Golf Course Customer and Calliope has received satisfactory evidence
of such shipment, (d) such Purchase Order shall not be unpaid more than thirty
(30) days from the date the Products listed in such Purchase Order have been
shipped to the applicable Golf Course Customer, (e) such Purchase Order has
not
been cancelled by the Approved Leasing Company or the Golf Course Customer
named
thereon, (f) the Golf Course Customer to whom the Products listed in such
Purchase Order have been shipped has not notified the Approved Leasing Company
that it is not accepting such Products, (g) if an Approved Leasing Company
has
succeeded to the rights of the lessor named in the Approved Lease covering
the
Products listed in such Purchase Order pursuant to an assignment of such
Approved Lease by ProLink Solutions, LLC, d/b/a ProLink Capital, the
consideration paid by the Approved Leasing Company to ProLink Solutions, LLC,
d/b/a ProLink Capital, under such assignment shall not be less than the amount
due under such Purchase Order, (h) Calliope has taken such action as it chooses
to verify the validity of such Purchase Order which verification may include,
without limitation, direct confirmation from the Approved Leasing Company and/or
the Golf Course Customer, (i) such Purchase Order, the Products listed thereon
and the related Purchase Order Proceeds are free and clear of all Liens except
Permitted Liens, and (j) such Purchase Order is otherwise satisfactory to
Calliope as determined by Calliope in the exercise of its sole
discretion.
“Eligible
Subsidiary”
means
each Subsidiary of the Parent set forth on Exhibit
A hereto,
as the same may be updated from time to time with Calliope’s written
consent.
“Equipment”
means
all “equipment” as such term is defined in the UCC, now owned or hereafter
acquired by any Person, wherever located, including any and all machinery,
apparatus, equipment, fittings, furniture, Fixtures, motor vehicles and other
tangible personal property (other than Inventory) of every kind and description
that may be now or hereafter used in such Person’s operations or that are owned
by such Person or in which such Person may have an interest, and all parts,
accessories and accessions thereto and substitutions and replacements
therefor.
“Equity
Interests”
shall
mean, with respect to any Person, any and all shares, rights to purchase,
options, warrants, general, limited or limited liability partnership interests,
member interests, units, participations or other equivalents of or interest
in
(regardless of how designated) equity of such Person, whether voting or
nonvoting, including common stock, preferred stock, convertible securities
or
any other “equity security” (as such term is defined in Rule 3a11-1 of the
General Rules and Regulations promulgated by the SEC (or any successor thereto)
under the Exchange Act).
“ERISA”
has
the
meaning given such term in Section 12(bb).
“Event
of Default”
means
the occurrence of any of the events set forth in Section 19.
“Exchange
Act”
means
the Securities Exchange Act of 1934, as amended.
“Exchange
Act Filings”
means
the Parent’s filings under the Exchange Act made prior to the date of this
Agreement.
“Existing
Indebtedness”
means
any and all obligations and liabilities of each Company owing to Comerica Bank,
FOC Financial Limited Partnership, Robeco WPG Distressed/Special Situations
Overseas, L.P. and Robeco WPG Event-Driven Multi-Strategy Overseas,
L.P..
8
“Financial
Reporting Controls”
has
the
meaning given such term in Section 12(f)(v).
“Fixtures”
means
all “fixtures” as such term is defined in the UCC, now owned or hereafter
acquired by any Person.
“Formula
Amount”
means
the Receivable Formula Amount and the Purchase Order Formula Amount,
collectively.
“GAAP”
means
generally accepted accounting principles, practices and procedures in effect
from time to time in the United States of America.
“General
Intangibles”
means
all “general intangibles” as such term is defined in the UCC, now owned or
hereafter acquired by any Person including all right, title and interest that
such Person may now or hereafter have in or under any contract, all Payment
Intangibles, customer lists, Licenses, Intellectual Property, interests in
partnerships, joint ventures and other business associations, permits,
proprietary or confidential information, inventions (whether or not patented
or
patentable), technical information, procedures, designs, knowledge, know-how,
Software, data bases, data, skill, expertise, experience, processes, models,
drawings, materials, Books and Records, Goodwill (including the Goodwill
associated with any Intellectual Property), all rights and claims in or under
insurance policies (including insurance for fire, damage, loss, and casualty,
whether covering personal property, real property, tangible rights or intangible
rights, all liability, life, key-person, and business interruption insurance,
and all unearned premiums), uncertificated securities, choses in action, deposit
accounts, rights to receive tax refunds and other payments, rights to received
dividends, distributions, cash, Instruments and other property in respect of
or
in exchange for pledged Stock and Investment Property, and rights of
indemnification.
“Golf
Course Customer”
means
a
golf course owner to which Products are shipped pursuant to a Purchase
Order.
“Goods”
means
all “goods”, as such term is defined in the UCC, now owned or hereafter acquired
by any Person, wherever located, including embedded software to the extent
included in “goods” as defined in the UCC, manufactured homes, fixtures,
standing timber that is cut and removed for sale and unborn young of
animals.
“Goodwill”
means
all goodwill, trade secrets, proprietary or confidential information, technical
information, procedures, formulae, quality control standards, designs, operating
and training manuals, customer lists, and distribution agreements now owned
or
hereafter acquired by any Person.
“Governmental
Authority”
means
any nation or government, any state or other political subdivision thereof,
and
any agency, department or other entity exercising executive, legislative,
judicial, regulatory or administrative functions of or pertaining to
government.
9
“Guaranty
Obligation”
means,
as applied to any Person, any direct or indirect liability, contingent or
otherwise, of such Person for any Indebtedness, lease, dividend or other
obligation (the “primary
obligation”)
of
another Person (the “primary
obligor”),
if
the purpose or intent of such Person in incurring such liability, or the
economic effect thereof, is to guarantee such primary obligation or provide
support, assurance or comfort to the holder of such primary obligation or to
protect or indemnify such holder against loss with respect to such primary
obligation, including (a) the direct or indirect guaranty, endorsement (other
than for collection or deposit in the ordinary course of business), co-making,
discounting with recourse or sale with recourse by such Person of any primary
obligation, (b) the incurrence of reimbursement obligations with respect to
any
letter of credit or bank guarantee in support of any primary obligation, (c)
the
existence of any Lien, or any right, contingent or otherwise, to receive a
Lien,
on the property of such Person securing any part of any primary obligation
and
(d) any liability of such Person for a primary obligation through any
Contractual Obligation (contingent or otherwise) or other arrangement (i) to
purchase, repurchase or otherwise acquire such primary obligation or any
security therefor or to provide funds for the payment or discharge of such
primary obligation (whether in the form of a loan, advance, stock purchase,
capital contribution or otherwise), (ii) to maintain the solvency, working
capital, equity capital or any balance sheet item, level of income or cash
flow,
liquidity or financial condition of any primary obligor, (iii) to make
take-or-pay or similar payments, if required, regardless of non-performance
by
any other party to any Contractual Obligation, (iv) to purchase, sell or lease
(as lessor or lessee) any property, or to purchase or sell services, primarily
for the purpose of enabling the primary obligor to satisfy such primary
obligation or to protect the holder of such primary obligation against loss
or
(v) to supply funds to or in any other manner invest in, such primary obligor
(including to pay for property or services irrespective of whether such property
is received or such services are rendered); provided, however, that “Guaranty
Obligations” shall not include (x) endorsements for collection or deposit in the
ordinary course of business and (y) product warranties given in the ordinary
course of business. The outstanding amount of any Guaranty Obligation shall
equal the outstanding amount of the primary obligation so guaranteed or
otherwise supported or, if lower, the stated maximum amount for which such
Person may be liable under such Guaranty Obligation.
“Hedging
Agreement”
means
any Interest Rate Contract, foreign exchange, swap, option or forward contract,
spot, cap, floor or collar transaction, any other derivative instrument and
any
other similar speculative transaction and any other similar agreement or
arrangement designed to alter the risks of any Person arising from fluctuations
in any underlying variable.
10
“Indebtedness”
of
any
Person means, without duplication, any of the following, whether or not matured:
(a) all indebtedness for borrowed money (including, without limitation, all
principal, interest, fees and charges relating thereto), (b) all obligations
evidenced by notes, bonds, debentures or similar instruments, (c) all
reimbursement and all obligations with respect to (i) letters of credit, bank
guarantees or bankers’ acceptances or (ii) surety, customs, reclamation or
performance bonds (in each case not related to judgments or litigation) other
than those entered into in the ordinary course of business, (d) all obligations
to pay the deferred purchase price of property or services, other than trade
payables incurred in the ordinary course of business, (e) all obligations
created or arising under any conditional sale or other title retention
agreement, regardless of whether the rights and remedies of the seller or lender
under such agreement in the event of default are limited to repossession or
sale
of such property, (f) all Capitalized Lease Obligations, (g) all obligations,
whether or not contingent, to purchase, redeem, retire, defease or otherwise
acquire for value any of its own Equity Interests (or any Equity Interests
of a
direct or indirect parent entity thereof) prior to the date that is 180 days
after the later of (i) the expiration of the Term Loan Term or (ii) the Revolver
Term, valued at, in the case of redeemable preferred Equity Interests, the
greater of the voluntary liquidation preference and the involuntary liquidation
preference of such Equity Interests plus accrued and unpaid dividends, (h)
all
payments that would be required to be made in respect of any Hedging Agreement
in the event of a termination (including an early termination) on the date
of
determination and (i) all Guaranty Obligations for obligations of any other
Person constituting Indebtedness of such other Person; provided, however, that
the items in each of clauses (a) through (i) above shall constitute
“Indebtedness” of such Person solely to the extent, directly or indirectly, (x)
such Person is liable for any part of any such item, (y) any such item is
secured by a Lien on such Person’s property or (z) any other Person has a right,
contingent or otherwise, to cause such Person to become liable for any part
of
any such item or to grant such a Lien.
“Instruments”
means
all “instruments”, as such term is defined in the UCC, now owned or hereafter
acquired by any Person, wherever located, including all certificated securities
and all promissory notes and other evidences of indebtedness, other than
instruments that constitute, or are a part of a group of writings that
constitute, Chattel Paper.
“Intellectual
Property”
means
any and all patents, trademarks, service marks, trade names, copyrights, trade
secrets, Licenses, information and other proprietary rights and
processes.
“Interest
Rate Contracts”
means
all interest rate swap agreements, interest rate cap agreements, interest rate
collar agreements and interest rate insurance.
“Inventory”
means
all “inventory”, as such term is defined in the UCC, now owned or hereafter
acquired by any Person, wherever located, including all inventory, merchandise,
goods and other personal property that are held by or on behalf of such Person
for sale or lease or are furnished or are to be furnished under a contract
of
service or that constitute raw materials, work in process, finished goods,
returned goods, or materials or supplies of any kind, nature or description
used
or consumed or to be used or consumed in such Person’s business or in the
processing, production, packaging, promotion, delivery or shipping of the same,
including all supplies and embedded software.
“Investment
Property”
means
all “investment property”, as such term is defined in the UCC, now owned or
hereafter acquired by any Person, wherever located.
“Investor
First Refusal Rights”
means
those rights granted by the Parent to Qualified Investors (as defined in the
SPA) pursuant to Section 4.8 of the SPA, as in effect on the date
hereof.
“Letter-of-Credit
Rights”
means
“letter-of-credit rights” as such term is defined in the UCC, now owned or
hereafter acquired by any Person, including rights to payment or performance
under a letter of credit, whether or not such Person, as beneficiary, has
demanded or is entitled to demand payment or performance.
11
“License”
means
any rights under any written agreement now or hereafter acquired by any Person
to use any trademark, trademark registration, copyright, copyright registration
or invention for which a patent is in existence or other license of rights
or
interests now held or hereafter acquired by any Person.
“Lien”
means
any mortgage, security deed, deed of trust, pledge, hypothecation, assignment,
security interest, lien (whether statutory or otherwise), charge, claim or
encumbrance, or preference, priority or other security agreement or preferential
arrangement held or asserted in respect of any asset of any kind or nature
whatsoever including any conditional sale or other title retention agreement,
any lease having substantially the same economic effect as any of the foregoing,
and the filing of, or agreement to give, any financing statement under the
UCC
or comparable law of any jurisdiction.
“Loans”
means
the Revolving Loans, the Term Loan and all other extensions of credit hereunder
and under any Ancillary Agreement.
“Lockboxes”
has
the
meaning given such term in Section 8(a).
“Material
Adverse Effect”
means
a
material adverse effect on (a) the business, assets, liabilities, condition
(financial or otherwise), properties, operations or prospects of any Company
or
any of its Subsidiaries (taken individually and as a whole), (b) any Company’s
or any of its Subsidiary’s ability to pay or perform the Obligations in
accordance with the terms hereof or any Ancillary Agreement, (c) the sufficiency
and/or value of the Collateral, the Liens on the Collateral or the priority
of
any such Lien or (d) the practical realization of the benefits of Calliope’s
rights and remedies under this Agreement and the Ancillary Agreements. Without
limiting the foregoing, any event or occurrence adverse to any Company that
results or could reasonably be expected to result in costs and/or liabilities
or
loss of revenues, individually or in the aggregate to such Company in excess
of
30% of such Company’s revenue shall constitute a Material Adverse
Effect.
“NASD”
has
the
meaning given such term in Section 13(b).
“Note
Shares”
has
the
meaning given such term in Section 12(a).
“Notes”
means
the Secured Revolving Note and the Secured Convertible Term Note made by
Companies in favor of Calliope in connection with the transactions contemplated
hereby, as each of the same may be amended, supplemented, restated and/or
otherwise modified from time to time.
“Obligations”
means
all Loans, all advances, debts, liabilities, obligations, covenants and duties
owing by each Company and each of its Subsidiaries to Calliope (or any
corporation that directly or indirectly controls or is controlled by or is
under
common control with Calliope) of every kind and description (whether or not
evidenced by any note or other instrument and whether or not for the payment
of
money or the performance or non-performance of any act), direct or indirect,
absolute or contingent, due or to become due, contractual or tortious,
liquidated or unliquidated, whether existing by operation of law or otherwise
now existing or hereafter arising including any debt, liability or obligation
owing from any Company and/or each of its Subsidiaries to others which Calliope
may have obtained by assignment or otherwise and further including all interest
(including interest accruing at the then applicable rate provided in this
Agreement after the maturity of the Loans and interest accruing at the then
applicable rate provided in this Agreement after the filing of any petition
in
bankruptcy, or the commencement of any insolvency, reorganization or like
proceeding, whether or not a claim for post-filing or post-petition interest
is
allowed or allowable in such proceeding), charges or any other payments each
Company and each of its Subsidiaries is required to make by law or otherwise
arising under or as a result of this Agreement or the Ancillary Agreements,
together with all reasonable expenses and reasonable attorneys’ fees chargeable
to the Companies’ or any of their Subsidiaries’ accounts or incurred by Calliope
in connection therewith.
12
“Payment
Intangibles”
means
all “payment intangibles” as such term is defined in the UCC, now owned or
hereafter acquired by any Person, including, a General Intangible under which
the Account Debtor’s principal obligation is a monetary obligation.
“Permitted
Liens”
means
(a) Liens of carriers, warehousemen, artisans, bailees, mechanics and
materialmen incurred in the ordinary course of business securing sums not
overdue; (b) Liens incurred in the ordinary course of business in connection
with worker’s compensation, unemployment insurance or other forms of
governmental insurance or benefits, relating to employees, securing sums (i)
not
overdue or (ii) being diligently contested in good faith provided that adequate
reserves with respect thereto are maintained on the books of the Companies
and
their Subsidiaries, as applicable, in conformity with GAAP; (c) Liens in
favor of Calliope; (d) Liens for taxes (i) not yet due or (ii) being diligently
contested in good faith by appropriate proceedings, provided that adequate
reserves with respect thereto are maintained on the books of the Companies
and
their Subsidiaries, as applicable, in conformity with GAAP; and which have
no
effect on the priority of Liens in favor of Calliope or the value of the assets
in which Calliope has a Lien; (e) Purchase Money Liens securing Purchase Money
Indebtedness to the extent permitted in this Agreement and (f) Liens specified
on Schedule
2.
“Person”
means
any individual, sole proprietorship, partnership, limited liability partnership,
joint venture, trust, unincorporated organization, association, corporation,
limited liability company, institution, public benefit corporation, entity
or
government (whether federal, state, county, city, municipal or otherwise,
including any instrumentality, division, agency, body or department thereof),
and shall include such Person’s successors and assigns.
“Principal
Market”
means
the NASD Over The Counter Bulletin Board, NASDAQ Capital Market, NASDAQ National
Market System, American Stock Exchange or New York Stock Exchange (whichever
of
the foregoing is at the time the principal trading exchange or market for the
Common Stock).
“Proceeds”
means
“proceeds”, as such term is defined in the UCC and, in any event, shall include:
(a) any and all proceeds of any insurance, indemnity, warranty or guaranty
payable to any Company or any other Person from time to time with respect to
any
Collateral; (b) any and all payments (in any form whatsoever) made or due and
payable to any Company from time to time in connection with any requisition,
confiscation, condemnation, seizure or forfeiture of any Collateral by any
governmental body, governmental authority, bureau or agency (or any person
acting under color of governmental authority); (c) any claim of any Company
against third parties (i) for past, present or future infringement of any
Intellectual Property or (ii) for past, present or future infringement or
dilution of any trademark or trademark license or for injury to the goodwill
associated with any trademark, trademark registration or trademark licensed
under any trademark License; (d) any recoveries by any Company against third
parties with respect to any litigation or dispute concerning any Collateral,
including claims arising out of the loss or nonconformity of, interference
with
the use of, defects in, or infringement of rights in, or damage to, Collateral;
(e) all amounts collected on, or distributed on account of, other Collateral,
including dividends, interest, distributions and Instruments with respect to
Investment Property and pledged Stock; (f) any and all other amounts, rights
to
payment or other property acquired upon the sale, lease, license, exchange
or
other disposition of Collateral and all rights arising out of Collateral; and
(g) Purchase Order Proceeds.
13
“Product”
means
the finished goods to be purchased by an Approved Leasing Company and delivered
to a Golf Course Customer pursuant to a Purchase Order.
“ProLink
UK”
means
ProLink UK, Ltd., a company organized under the laws of England and
Wales.
“Purchase
Money Indebtedness”
means
(a) any indebtedness incurred for the payment of all or any part of the purchase
price of any fixed asset, including indebtedness under capitalized leases,
(b)
any indebtedness incurred for the sole purpose of financing or refinancing
all
or any part of the purchase price of any fixed asset, and (c) any renewals,
extensions or refinancings thereof (but not any increases in the principal
amounts thereof outstanding at that time).
“Purchase
Money Lien”
means
any Lien upon any fixed assets that secures the Purchase Money Indebtedness
related thereto but only if such Lien shall at all times be confined solely
to
the asset the purchase price of which was financed or refinanced through the
incurrence of the Purchase Money Indebtedness secured by such Lien and only
if
such Lien secures only such Purchase Money Indebtedness.
“Purchase
Order”
means
a
purchase order delivered to any Company from an Approved Leasing Company in
the
ordinary course of its business.
“Purchase
Order Availability”
means
the lesser of (a) ninety percent (90%) of the Purchase Order Price set forth
in
the Eligible Purchase Orders and (b) $1,000,000; provided, however, that in
calculating the amount of Purchase Order Availability, the aggregate amount
of
availability generated from Approved Leases with Approved Leasing Companies
other than US Express Leasing or VGM Financial shall not exceed $200,000 at
any
time.
“Purchase
Order Formula Amount”
has
the
meaning given such term in Section 2(a)(i)(B).
“Purchase
Order Inventory”
means
the Inventory consisting of Products required to satisfy a Purchase
Order.
“Purchase
Order Invoice”
means
the invoice rendered upon delivery of the Products pursuant to a Purchase
Order.
14
“Purchase
Order Price”
means
the purchase price set forth in the Purchase Order to be paid by an Approved
Leasing Company for Products that are shipped to a Golf Course
Customer.
“Purchase
Order Proceeds”
means
payments received on account of Purchase Order Invoices (whether paid by a
Approved Leasing Company or any other Person).
“Purchase
Order Revolving Loans”
has
the
meaning given such term in Section 2(a)(i)(B).
“Registration
Rights Agreements”
means
that certain Registration Rights Agreement dated as of the Closing Date by
and
between the Parent and Calliope and each other registration rights agreement
by
and between the Parent and Calliope, as each of the same may be amended,
modified and supplemented from time to time.
“Revolver
Term”
means
the Closing Date through the close of business on the day immediately preceding
the second anniversary of the Closing Date, subject to acceleration at the
option of Calliope upon the occurrence of an Event of Default hereunder or
other
termination hereunder.
“Revolving
Loans”
has
the
meaning given such term in Section 2(a)(i)(B).
“SEC”
means
the Securities and Exchange Commission.
“SEC
Reports”
has
the
meaning given such term in Section 12(u).
“Secured
Revolving Note”
means
that certain Secured Revolving Note dated as of the Closing Date made by the
Companies in favor of Calliope in the original face amount of Five Million
Dollars ($5,000,000), as the same may be amended, supplemented, restated and/or
otherwise modified from time to time.
“Secured
Convertible Term Note”
means
that certain Secured Convertible Term Note dated as of the Closing Date made
by
the Companies in favor of Calliope in the original face amount of Four Million
Dollars ($4,000,000), as the same may be amended, supplemented, restated and/or
otherwise modified from time to time.
“Securities”
means
the Notes and the Warrants and the shares of Common Stock which may be issued
pursuant to conversion of the Secured Convertible Term Note in whole or in
part
exercise of such Warrants.
“Securities
Act”
has
the
meaning given such term in Section 12(r).
“Security
Documents”
means
all security agreements, mortgages, cash collateral deposit letters, pledges
and
other agreements which are executed in connection with this Agreement by any
Company or any of its Subsidiaries in favor of Calliope.
15
“Software”
means
all “software” as such term is defined in the UCC, now owned or hereafter
acquired by any Person, including all computer programs and all supporting
information provided in connection with a transaction related to any
program.
“Solvent”
means,
with respect to any Person on a particular date, that on such date (a) the
fair
value of the property of such Person is greater than the total amount of
liabilities, including contingent liabilities, of such Person; (b) the present
fair salable value of the assets of such Person is not less than the amount
that
will be required to pay the probable liability of such Person on its debts
as
they become absolute and matured; (c) such Person does not intend to, and does
not believe that it will, incur debts or liabilities beyond such Person’s
ability to pay as such debts and liabilities mature; and (d) such Person is
not
engaged in a business or transaction, and is not about to engage in a business
or transaction, for which such Person’s property would constitute and
unreasonably small capital. The amount of contingent liabilities (such as
litigation, guaranties and pension plan liabilities) at any time shall be
computed as the amount that, in light of all the facts and circumstances
existing at the time, represents the amount that can reasonably be expected
to
become an actual or matured liability.
“SPA”
means
that certain Securities Purchase Agreement dated as of December 31, 2006 by
and
among ProLink Holdings Corp. and the investors listed on the Schedule of
Investors attached thereto as in effect on the date thereof.
“Stock”
means
all certificated and uncertificated shares, options, warrants, membership
interests, general or limited partnership interests, participation or other
equivalents (regardless of how designated) of or in a corporation, partnership,
limited liability company or equivalent entity whether voting or nonvoting,
including common stock, preferred stock, or any other “equity security” (as such
term is defined in Rule 3a11-1 of the General Rules and Regulations promulgated
by the SEC under the Securities Exchange Act of 1934).
“Subsidiary”
means,
with respect to any Person, (i) any other Person whose shares of stock or other
ownership interests having ordinary voting power (other than stock or other
ownership interests having such power only by reason of the happening of a
contingency) to elect a majority of the directors or other governing body of
such other Person, are owned, directly or indirectly, by such Person or (ii)
any
other Person in which such Person owns, directly or indirectly, more than 50%
of
the equity interests at such time.
“Supporting
Obligations”
means
all “supporting obligations” as such term is defined in the UCC.
“Term”
means
(a) with respect to the Revolving Loans, the Revolver Term and (b) with respect
to the Term Loan, the Term Loan Term.
“Term
Loan”
has
the
meaning given such term in Section 2(b).
“Term
Loan Term”
means
the Closing Date through the close of business on the day immediately preceding
the fifth anniversary of the Closing Date, subject to acceleration at the option
of Calliope upon the occurrence of an Event of Default hereunder or other
termination hereunder.
16
“UCC”
means
the Uniform Commercial Code as the same may, from time to time be in effect
in
the State of New York; provided, that in the event that, by reason of mandatory
provisions of law, any or all of the attachment, perfection or priority of,
or
remedies with respect to, Calliope’s Lien on any Collateral is governed by the
Uniform Commercial Code as in effect in a jurisdiction other than the State
of
New York, the term “UCC” shall mean the Uniform Commercial Code as in effect in
such other jurisdiction for purposes of the provisions of this Agreement
relating to such attachment, perfection, priority or remedies and for purposes
of definitions related to such provisions; provided further, that to the extent
that UCC is used to define any term herein or in any Ancillary Agreement and
such term is defined differently in different Articles or Divisions of the
UCC,
the definition of such term contained in Article or Division 9 shall
govern.
“Warrant
Shares”
has
the
meaning given such term in Section 12(a).
“Warrants”
means
those certain Common Stock Purchase Warrants dated as of the Closing Date made
by the Parent in favor of Calliope and each other warrant made by the Parent
in
favor Calliope, as each of the same may be amended, restated, modified and/or
supplemented from time to time.
17
Exhibit
A
Eligible
Subsidiaries
ProLink
Solutions, LLC
Exhibit
B
Borrowing
Base Certificate
As
of
__________ __, 200__
ACCOUNTS
RECEIVABLE per __________
Aging
|
|
|
0.00
|
|||||||
|
|
|||||||||
Ineligible
Accounts:
|
|
|
||||||||
Accounts
over 90 days from Invoice Date
|
|
0.00
|
||||||||
Credit
Balances Over 90 days from Invoice Date
|
|
0.00
|
||||||||
Intercompany
and Affiliate Accounts
|
|
0.00
|
||||||||
25%
Concentration Cap
|
|
0.00
|
||||||||
Contra
Accounts
|
|
0.00
|
||||||||
Cash
Sales and COD Accounts
|
|
0.00
|
||||||||
Non-Eligible
Foreign Receivables
|
|
0.00
|
||||||||
Government
Receivables (without Assignment of Claims)
|
|
0.00
|
||||||||
Discounts,
Credits and Allowances
|
|
0.00
|
||||||||
Cross-age
(25% Past Due)
|
|
0.00
|
||||||||
Xxxx
and Hold Invoices
|
|
0.00
|
||||||||
Finance/Service/Late
Charges
|
|
0.00
|
||||||||
Other:
|
|
0.00
|
0.00
|
|||||||
|
|
|||||||||
ELIGIBLE
ACCOUNTS RECEIVABLE
|
|
|
0.00
|
|||||||
|
|
|||||||||
ELIGIBLE
CREDIT INSURED ACCOUNTS
RECEIVABLE
|
|
|
0.00
|
|||||||
|
|
|||||||||
Accounts
Receivable Advance Rate
|
90
|
%
|
|
|||||||
|
|
|
||||||||
ACCOUNTS
RECEIVABLE AVAILABILITY
|
|
|
0.00
|
|||||||
|
|
|||||||||
ELIGIBLE
PURCHASE ORDERS
|
|
|
0.00
|
|||||||
|
|
|||||||||
Purchase
Order Advance Rate
|
90
|
%
|
|
|||||||
Purchase
Order Cap
|
$
|
1,000,000
|
|
|||||||
Non
USXL/VGM Purchase Order Sublimit
|
$
|
200,000
|
|
|||||||
|
|
|
||||||||
PURCHASE
ORDER AVAILABILITY
|
|
|
0.00
|
|||||||
|
|
|||||||||
TOTAL
AVAILABILITY
|
|
|
0.00
|
|||||||
|
|
|||||||||
Less
Reserves
|
|
|
0.00
|
|||||||
|
|
|||||||||
NET
AVAILABILITY
|
|
|
0.00
|
|||||||
|
|
|||||||||
REVOLVING
CREDIT LINE
|
|
$
|
4,000,000
|
|||||||
|
|
|||||||||
NET
BORROWING AVAILABILITY (Lesser of Line or Net
Availability)
|
|
|
0.00
|
|||||||
|
|
|||||||||
Less:
Calliope Revolving Loans
|
|
|
0.00
|
|||||||
|
|
|||||||||
EXCESS/(DEFICIT)
AVAILABILITY
|
|
|
0.00
|
The
undersigned hereby certifies that all of the foregoing information regarding
the
Eligible Accounts, Eligible Credit Insured Accounts and Eligible Purchase Orders
are true and correct on the date hereof and all such Accounts and Purchase
Orders listed as eligible are eligible within the meaning given such term in
the
Security Agreement dated as of August 17, 2007 among ProLink Holdings Corp.,
the
other companies named therein and Calliope Capital Corporation.
PROLINK
HOLDINGS CORP., as Company Agent
|
|
By:
|
|
Name:
|
|
Title:
|
2
Exhibit
C
Compliance
Certificate
See
attached.